<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2021.642856</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Timing and Abundance of IL-2R&#x3b2; (CD122) Expression Control Thymic <italic>i</italic>NKT Cell Generation and NKT1 Subset Differentiation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Won</surname>
<given-names>Hee Yeun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1186841"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Hye Kyung</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/628671"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Crossman</surname>
<given-names>Assiatu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Awasthi</surname>
<given-names>Parirokh</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gress</surname>
<given-names>Ronald E.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Park</surname>
<given-names>Jung-Hyun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/288846"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute</institution>, <addr-line>National Institutes of Health, Bethesda, MD</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Experimental Transplantation and Immunotherapy Branch, Center for Cancer Research, National Cancer Institute</institution>, <addr-line>National Institutes of Health, Bethesda, MD</addr-line>, <country>United States</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Laboratory Animal Sciences Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research</institution>, <addr-line>Frederick, MD</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Hongbo Chi, St. Jude Children&#x2019;s Research Hospital, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Xiao-Ping Zhong, Duke University Medical Center, United States; Kai Yang, Indiana University &#x2013; Lafayette, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Jung-Hyun Park, <email xlink:href="mailto:parkhy@mail.nih.gov">parkhy@mail.nih.gov</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to T Cell Biology, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>05</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>642856</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>12</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>04</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Won, Kim, Crossman, Awasthi, Gress and Park</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Won, Kim, Crossman, Awasthi, Gress and Park</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Invariant NKT (<italic>i</italic>NKT) cells are thymus-generated innate-like T cells, comprised of three distinct subsets with divergent effector functions. The molecular mechanism that drives the lineage trifurcation of immature <italic>i</italic>NKT cells into the NKT1, NKT2, and NKT17 subsets remains a controversial issue that remains to be resolved. Because cytokine receptor signaling is necessary for <italic>i</italic>NKT cell generation, cytokines are proposed to contribute to <italic>i</italic>NKT subset differentiation also. However, the precise roles and requirements of cytokines in these processes are not fully understood. Here, we show that IL-2R&#x3b2;, a nonredundant component of the IL-15 receptor complex, plays a critical role in both the development and differentiation of thymic <italic>i</italic>NKT cells. While the induction of IL-2R&#x3b2; expression on postselection thymocytes is necessary to drive the generation of <italic>i</italic>NKT cells, surprisingly, premature IL-2R&#x3b2; expression on immature <italic>i</italic>NKT cells was detrimental to their development. Moreover, while IL-2R&#x3b2; is necessary for NKT1 generation, paradoxically, we found that the increased abundance of IL-2R&#x3b2; suppressed NKT1 generation without affecting NKT2 and NKT17 cell differentiation. Thus, the timing and abundance of IL-2R&#x3b2; expression control <italic>i</italic>NKT lineage fate and development, thereby establishing cytokine receptor expression as a critical regulator of thymic <italic>i</italic>NKT cell differentiation.</p>
</abstract>
<kwd-group>
<kwd>cytokines</kwd>
<kwd>IL-2 (interleukin-2)</kwd>
<kwd>IL-15</kwd>
<kwd>Tbet</kwd>
<kwd>thymocytes</kwd>
</kwd-group>
<contract-num rid="cn001">Intramural Research</contract-num>
<contract-sponsor id="cn001">National Cancer Institute<named-content content-type="fundref-id">10.13039/100000054</named-content>
</contract-sponsor>
<counts>
<fig-count count="6"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="54"/>
<page-count count="15"/>
<word-count count="8539"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Cytokines of the common &#x3b3;-chain (&#x3b3;c) family play critical roles in the generation and differentiation of T cells in the thymus (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B3">3</xref>). Importantly, &#x3b3;c cytokines not only provide prosurvival signals and metabolic cues, but they also specify the lineage commitment of thymocytes and equip developing T cells with effector function (<xref ref-type="bibr" rid="B1">1</xref>). Along these lines, a requirement for intrathymic interleukin-7 (IL-7) in T cell development is well established, as documented in its role to control the expansion of immature thymocytes and to determine CD8 cytotoxic T cell lineage fate (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B4">4</xref>). IL-4, on the other hand, drives the differentiation of innate-like CD8 T cells (<xref ref-type="bibr" rid="B5">5</xref>), whereas IL-2 signaling is critical for the generation of Foxp3<sup>+</sup> T regulatory (Treg) cells (<xref ref-type="bibr" rid="B6">6</xref>). Collectively, &#x3b3;c cytokine signaling is necessary for the development of &#x3b1;&#x3b2; T cells; however, the identity of the required cytokine differs depending on the individual lineages or subsets of T cells that are generated.</p>
<p>Cytokine signaling is also important for the generation of invariant NKT (<italic>i</italic>NKT) cells, a population of innate-like &#x3b1;&#x3b2; T cells that are produced in the thymus (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). <italic>i</italic>NKT cells are potent immunoregulatory cells that produce pro-inflammatory cytokines, but they differ from conventional &#x3b1;&#x3b2; T cells because they acquire effector function before antigen encounter and activation (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). Depending on the cytokines they produce and the transcription factors they express, <italic>i</italic>NKT cells can be categorized into three distinct subsets (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>). <italic>i</italic>NKT cells that are T-bet<sup>+</sup> and produce IFN&#x3b3; correspond to NKT1 cells. IL-17-producing ROR&#x3b3;t<sup>+</sup> <italic>i</italic>NKT cells, on the other hand, are NKT17 cells, and IL-4-producing PLZF<sup>hi</sup> <italic>i</italic>NKT cells are NKT2 cells (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>). The molecular mechanisms that drive <italic>i</italic>NKT subset differentiation are not fully mapped. However, cytokines have been implicated in determining <italic>i</italic>NKT subset specification. Thus, IL-15 promotes NKT1 cell development (<xref ref-type="bibr" rid="B11">11</xref>), TGF-&#x3b2; induces NKT17 cell generation (<xref ref-type="bibr" rid="B12">12</xref>), and IL-25 produced by thymic tuft cells possibly drives the differentiation of NKT2 cells (<xref ref-type="bibr" rid="B13">13</xref>). Consequently, cytokines can specify the differentiation of <italic>i</italic>NKT cells in the thymus. However, it remains unclear why some <italic>i</italic>NKT precursors would respond to IL-15 and become NKT1 cells, whereas other precursors are refractory to IL-15 and choose other lineage fates. This problem is further compounded by all <italic>i</italic>NKT cells expressing the same semi-invariant TCR so that differences in the TCR repertoire are unlikely to play a significant role in subset differentiation. Instead, we consider it likely that differences in the timing or abundance of cytokine receptors could determine the responsiveness to subset-specifying cytokines.</p>
<p>Among <italic>i</italic>NKT cells, the NKT1 subset is of particular interest because it comprises most of the thymic <italic>i</italic>NKT cells in C57BL/6 mice. NKT1 cells are also important because they produce copious amounts of IFN&#x3b3;, which affects T cell lineage differentiation and promotes the terminal maturation of thymic epithelial cells (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>). NKT1 cells require IL-15 for their generation, whereby intrathymic IL-15 is primarily provided by medullary thymic epithelial cells (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>). IL-15 is a &#x3b3;c family cytokine that signals through &#x3b3;c and IL-2R&#x3b2;  (<xref ref-type="bibr" rid="B3">3</xref>). Consistent with its requirement for IL-15 signaling, IL-2R&#x3b2; deficiency was previously shown to dramatically impair the generation of <italic>i</italic>NKT cells in the thymus (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). However, it remains unclear whether the lack of IL-2R&#x3b2; would specifically impede the generation of NKT1 cells or the differentiation of all thymic <italic>i</italic>NKT subsets. Moreover, if IL-2R&#x3b2; is <italic>necessary</italic> for NKT1 cell differentiation, we wished to assess whether IL-2R&#x3b2; would be <italic>sufficient</italic> to drive NKT1 cell generation. If such were the case, we expected that the forced expression of IL-2R&#x3b2; would impose the NKT1 subset fate onto all developing <italic>i</italic>NKT cells, resulting in a heavily skewed <italic>i</italic>NKT subset composition where NKT1 cells would be overrepresented and NKT2 and NKT17 cells would be underrepresented. To this end, we examined the generation and differentiation of <italic>i</italic>NKT cells in IL-2R&#x3b2;<sup>Tg</sup> mice in both the C57BL/6 and BALB/c backgrounds, and further generated mice with conditional deletion of IL-2R&#x3b2; upon <italic>i</italic>NKT lineage commitment. Here, we show that not only the expression itself but also the carefully curated timing of IL-2R&#x3b2; induction is important for the generation and subset differentiation of <italic>i</italic>NKT cells. Collectively, these results unveil previously unappreciated roles and requirements of the cytokine receptor IL-2R&#x3b2; in controlling thymic <italic>i</italic>NKT cell development.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2_1">
<title>Mice</title>
<p>C57BL/6NCrl (C57BL/6) and BALB/cAnNCrl (BALB/c) mice were obtained from the Charles River Laboratories (Frederick, MD). IL-2R&#x3b2;<sup>Tg</sup> mice were generated in house as previously described (<xref ref-type="bibr" rid="B20">20</xref>). IL-2R&#x3b2;-deficient mice (<italic>Il2rb</italic>
<sup>&#x2013;/&#x2013;</sup>) and IL-2R&#x3b2;-floxed mice (<italic>Il2rb</italic>
<sup>fl/fl</sup>) were obtained from the Jackson Laboratories (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>). PLZF<sup>Cre</sup> transgenic mice were kindly provided by Dr. D. Sant&#x2019;Angelo (Rutgers University, NJ) (<xref ref-type="bibr" rid="B23">23</xref>). CA-STAT5<sup>Tg</sup> mice were a kind gift from by Dr. M. A. Farrar (U. Minnesota, MN) (<xref ref-type="bibr" rid="B24">24</xref>). T-bet-ZsGreen reporter transgenic mice (TBGR<sup>Tg</sup>) on C57BL/6 background were a kind gift from Dr. Jinfang Zhu (NIAID, NIH) (<xref ref-type="bibr" rid="B25">25</xref>), and these mice were backcrossed to BALB/cAnNCrl for at least 6 generations before analysis. All experimental mice were analyzed between 6 and 12 weeks of age, except for <italic>Il2rb</italic>
<sup>&#x2013;/&#x2013;</sup> and their littermate controls, which were analyzed between 4 and 6 weeks of age. All mice were cared for in accordance with NIH guidelines. Animal experiments were approved by the NCI Animal Care and Use Committee.</p>
</sec>
<sec id="s2_2">
<title>Flow Cytometry</title>
<p>Single-cell suspensions were prepared from the indicated tissues and stained with fluorescence-conjugated antibodies as previously described (<xref ref-type="bibr" rid="B26">26</xref>). The data were acquired using LSR Fortessa or LSRII flow cytometers (BD Biosciences) and were analyzed using software platforms developed by the EIB Flow Cytometry Facility, CCR, NCI, NIH. Live cells were gated by forward scatter exclusion of dead cells stained with propidium iodide. The following antibodies were used for staining: HSA (M1/69), T-bet (4B10), Foxp3 (FJK-16s), ROR&#x3b3;t (AKFJS-9) and isotype control antibodies, all from eBioscience; CD4 (GK1.5 and RM4.5), CD8&#x3b1; (53&#x2013;6&#x2013;7), CD69 (H1.2F3), TCR&#x3b2; (H57-597) and IL2R&#x3b2; (TM-&#x3b2;1) from BD Biosciences; CD44 (IM7), NK1.1 (PK136), IL2R&#x3b1; (PC61), CCR7 (4B12) and PLZF (9E12) from BioLegend. Fluorochrome-conjugated CD1d tetramers loaded with PBS-57 (CD1dTet) and unloaded controls were obtained from the NIH tetramer facility (Emory University, Atlanta, GA). Intracellular Foxp3, PLZF, ROR&#x3b3;t, and T-bet proteins were detected using a Foxp3 staining kit according to the manufacturer&#x2019;s instructions (eBioscience Thermo Fisher).</p>
</sec>
<sec id="s2_3">
<title>
<italic>i</italic>NKT Subset Identification by Transcription Factors</title>
<p>To identify the subset composition of <italic>i</italic>NKT cells, total thymocytes were first stained with PBS-57-loaded mouse CD1d tetramers, fixed, permeabilized and then stained for nuclear transcription factors. Briefly, thymocytes were stained with fluorochrome-conjugated CD1d tetramers in FACS buffer (0.5% BSA, 0.1% sodium azide in Ca<sup>2+</sup> and Mg<sup>2+</sup>-free HBSS) for 20&#xa0;minutes at 4&#xb0;C. Without removing the tetramer reagents, the cells were incubated for an additional 30&#xa0;min at 4&#xb0;C with antibodies for surface markers. Excess reagents were then washed out with FACS buffer, and the cells were resuspended in a 1:3 mixture of concentrate/diluent working solution of the Foxp3 Transcription Factor Staining Buffer kit (eBioscience Thermo Fisher), followed by incubation at room temperature for 20 minutes. Next, the cells were washed twice with 1&#xd7; permeabilization buffer (eBioscience Thermo Fisher) before adding antibodies for transcription factors, specifically antibodies against PLZF, ROR&#x3b3;t and T-bet. The cells were incubated at room temperature for 1 hour before washing out excess reagents with FACS buffer and analysis by flow cytometry.</p>
</sec>
<sec id="s2_4">
<title>Alzet Osmotic Pump Installation</title>
<p>Recombinant mouse IL-15 (Peprotech) dissolved in PBS was administered into IL-2R&#x3b2;<sup>Tg</sup> BALB/c mice using Alzet osmotic pumps (Durect) following the manufacturer&#x2019;s instruction. The pumps (model 1002) were set to release IL-15 at a rate of 3 &#xb5;g of recombinant IL-15 per 24 hours.</p>
</sec>
<sec id="s2_5">
<title>Statistical Analysis</title>
<p>The data were shown as the means &#xb1; SEM. Statistical significance was determined by unpaired two-tailed Student&#x2019;s <italic>t</italic>-test. <italic>P</italic> values of less than 0.05 were considered significant. *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, ***<italic>P &lt;</italic>0.001. All statistical analysis was performed using GraphPad Prism 7 software (GraphPad software).</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>IL-2R&#x3b2; Expression Is Induced Upon Thymic <italic>i</italic>NKT Cell Differentiation</title>
<p>To understand the role of IL-2R&#x3b2; in thymic <italic>i</italic>NKT cell generation, we first examined IL-2R&#x3b2; expression on <italic>i</italic>NKT cells in the context of &#x3b1;&#x3b2; T cell development in the thymus. The process of thymocyte positive selection and maturation can be visualized using the combination of the two surface markers CD69 and CCR7 which identifies 5 distinct developmental stages, progressing from stage I to stage V (<xref ref-type="fig" rid="f1">
<bold>Figure 1A</bold>
</xref>, top) (<xref ref-type="bibr" rid="B27">27</xref>). TCR engagement of immature thymocytes (stage I) induces the expression CD69 (stage II) followed by the upregulation of the chemokine receptor CCR7, so that CD69<sup>+</sup>CCR7<sup>int</sup> cells (stage III) correspond to thymocytes undergoing positive selection and lineage commitment. Stage IV and V cells, on the other hand, correspond to postselection thymocytes. We found that <italic>i</italic>NKT cells, as identified by PBS-57-loaded CD1d tetramers (CD1dTet<sup>+</sup>), arise as early as in stage I, and that they were then prominent in stage II (<xref ref-type="fig" rid="f1">
<bold>Figure 1A</bold>
</xref>, bottom). Importantly, stage I <italic>i</italic>NKT cells expressed both the cytokine receptor &#x3b3;c and IL-2R&#x3b2; (<xref ref-type="fig" rid="f1">
<bold>Figure 1B</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 1</bold>
</xref>), indicating that the induction of IL-2R&#x3b2; is one of the earliest events in <italic>i</italic>NKT cell development. Indeed, such kinetics of IL-2R&#x3b2; expression differed substantially from that of CD1dTet-negative conventional &#x3b1;&#x3b2; T cells, which remained mostly absent for IL-2R&#x3b2; expression throughout their development (<xref ref-type="fig" rid="f1">
<bold>Figure 1B</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 2</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure 1</label>
<caption>
<p>IL-2R&#x3b2; expression on thymic <italic>i</italic>NKT cells <bold>(A)</bold> C57BL/6 thymocytes were assessed for surface CD69 and CCR7 staining, which visualizes 5 distinct stages of differentiation (<italic>i.e.</italic>, stages I&#x2013;V), whereby thymocytes undergoing positive selection correspond to population III (top). <italic>i</italic>NKT cells were identified by PBS57-loaded CD1d tetramer (CD1dTet) staining among the 5 stages defined by CD69 and CCR7 (bottom). The results are representative of 5 independent experiments with a total of 5 WT C57BL/6 mice. <bold>(B)</bold> Surface cytokine receptor expression on thymic <italic>i</italic>NKT cell populations. <italic>i</italic>NKT cells in populations I, II, and III were assessed for &#x3b3;c and IL-2R&#x3b2; expression (red lines). Isotype control antibody staining are shown as gray lines. The results are representative of 3 independent experiments. <bold>(C)</bold> IL-2R&#x3b2; expression during <italic>i</italic>NKT cell differentiation. Thymic <italic>i</italic>NKT cells were divided into immature ST0 and mature stage 1&#x2013;3 cells based on HSA expression (left, top). The abundance of IL-2R&#x3b2; was then assessed on ST0 (HSA<sup>hi</sup>CD44<sup>&#x2013;</sup>), ST1 (CD44<sup>&#x2013;</sup>NK1.1<sup>&#x2013;</sup>), ST2 (CD44<sup>+</sup>NK1.1<sup>&#x2013;</sup>), and ST3 (CD44<sup>+</sup>NK1.1<sup>+</sup>) <italic>i</italic>NKT cells (left, bottom). Histograms show surface IL-2R&#x3b2; expression for each subset (red line). Isotype control antibody staining are shown as gray lines. The results are representative of 5 independent experiments. <bold>(D)</bold> IL-2R&#x3b2; expression in thymic <italic>i</italic>NKT subsets. <italic>i</italic>NKT cells were assessed for intracellular PLZF and ROR&#x3b3;t expression to identify NKT1, NKT2, and NK17 cells (left). Each <italic>i</italic>NKT subset was assessed for IL-2R&#x3b2; expression (right, red lines). Isotype control antibody staining are shown as gray lines. The results are representative of 3 independent experiments.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-642856-g001.tif"/>
</fig>
<p>To further align IL-2R&#x3b2; expression with the selection and maturation of <italic>i</italic>NKT cells, we next assessed surface IL-2R&#x3b2; expression in developmental stages of thymic <italic>i</italic>NKT cells. CD44-negative HSA<sup>hi</sup> thymocytes that bind PBS-57-loaded CD1d tetramers correspond to preselection <italic>i</italic>NKT cells, and they are usually referred to as stage 0 (ST0) <italic>i</italic>NKT cells (<xref ref-type="bibr" rid="B28">28</xref>). IL-2R&#x3b2; was mostly absent on ST0 <italic>i</italic>NKT cells but was induced following differentiation into HSA<sup>lo</sup> mature <italic>i</italic>NKT cells (<xref ref-type="fig" rid="f1">
<bold>Figure 1C</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 1B</bold>
</xref>). Thymic differentiation of HSA<sup>lo</sup> <italic>i</italic>NKT cells proceeds along a well-characterized pathway that is marked by the expression of CD44 and NK1.1, whereby CD44<sup>&#x2013;</sup>NK1.1<sup>&#x2013;</sup> cells correspond to stage 1 (ST1), followed by CD44<sup>+</sup>NK1.1<sup>&#x2013;</sup> cells that are stage 2 (ST2), and terminally differentiate into CD44<sup>+</sup>NK1.1<sup>+</sup> stage 3 cells (ST3) (<xref ref-type="bibr" rid="B28">28</xref>). Interestingly, IL-2R&#x3b2; was expressed at low levels on ST1 and ST2 cells but highly expressed on ST3 <italic>i</italic>NKT cells (<xref ref-type="fig" rid="f1">
<bold>Figure 1C</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 1B</bold>
</xref>). Thus, all mature thymic <italic>i</italic>NKT cells express IL-2R&#x3b2; to a certain degree, but the amount of surface IL-2R&#x3b2; proteins substantially increases with maturation.</p>
<p>Mature <italic>i</italic>NKT cells are also categorized into 3 distinct subsets, namely NKT1, NKT2, and NKT17 cells, based on their transcription factor expression profiles (<xref ref-type="bibr" rid="B10">10</xref>). Differential expression of the transcription factors PLZF <italic>versus</italic> ROR&#x3b3;t can visualize these three subsets, which we utilized to assess IL-2R&#x3b2; expression on individual thymic <italic>i</italic>NKT subsets (<xref ref-type="fig" rid="f1">
<bold>Figure 1D</bold>
</xref>). Consistent with previous observations (<xref ref-type="bibr" rid="B10">10</xref>), IL-2R&#x3b2; was highly induced on NKT1 cells and minimally expressed on PLZF<sup>hi</sup>ROR&#x3b3;t<sup>neg</sup> NKT2 and PLZF<sup>int</sup>ROR&#x3b3;t<sup>+</sup> NKT17 cells (<xref ref-type="fig" rid="f1">
<bold>Figure 1D</bold>
</xref>). Altogether, these results demonstrated that IL-2R&#x3b2; is highly upregulated on terminally differentiated ST3 <italic>i</italic>NKT cells and that such IL-2R&#x3b2;<sup>+</sup> <italic>i</italic>NKT cells correspond to NKT1 cells.</p>
</sec>
<sec id="s3_2">
<title>Conditional Deletion of IL-2R&#x3b2; in PLZF<sup>+</sup> Thymocytes</title>
<p>Having established that IL-2R&#x3b2; expression is <italic>associated</italic> with <italic>i</italic>NKT cell maturation, we next wished to examine whether IL-2R&#x3b2; would be also <italic>required</italic> for the development and differentiation of <italic>i</italic>NKT cells. To this end, we aimed to set up an experimental system where IL-2R&#x3b2; would be selectively deleted in <italic>i</italic>NKT cells. The zinc finger transcription factor PLZF is expressed in <italic>i</italic>NKT cells but absent in conventional T cells (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>). Thus, we bred PLZF-Cre transgenic mice (PLZF<sup>Cre</sup>) with <italic>Il2rb</italic>
<sup>fl/fl</sup> mice (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B23">23</xref>) to generate <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> mice and to specifically delete IL-2R&#x3b2; in <italic>i</italic>NKT cells. In such <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> mice, the thymic development of conventional T cells was unaffected (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 3A</bold>
</xref>). Both TCR&#x3b2; expression and the CD4 <italic>versus</italic> CD8 profiles of <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> thymocytes remained comparable to those of littermate <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>WT</sup> thymocytes (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 3A</bold>
</xref>). Contrary to our expectation, however, the frequency and number of thymic <italic>i</italic>NKT cells also remained unaltered in <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> mice (<xref ref-type="fig" rid="f2">
<bold>Figure 2A</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure 2</label>
<caption>
<p>
<italic>i</italic>NKT cell generation and differentiation in IL-2R&#x3b2;-floxed PLZF-Cre mice <bold>(A)</bold> Frequency and number of thymic <italic>i</italic>NKT cells in <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> and <italic>Il2rb</italic>
<sup>fl/fl</sup> littermate control mice. The dot plots show thymic <italic>i</italic>NKT cells as identified by CD1dTet <italic>versus</italic> TCR&#x3b2; staining (top). The bar graphs show the frequencies and numbers of <italic>i</italic>NKT cells from the indicated mice (bottom). The dot plot is representative, and the bar graphs are a summary of 4 independent experiments with a total of 11 <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> and 5 <italic>Il2rb</italic>
<sup>fl/fl</sup> littermate control mice. <bold>(B)</bold> IL-2R&#x3b2;-deletion efficiency in <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> <italic>i</italic>NKT cells. The dot plots show thymic <italic>i</italic>NKT cells of the indicated mice CD1dTet <italic>versus</italic> HSA staining. HSA<sup>hi</sup>CD44<sup>&#x2013;</sup> cells correspond to ST0 immature <italic>i</italic>NKT cells while HSA<sup>lo</sup> cells are mature ST1-3 <italic>i</italic>NKT cells. The histograms show GFP expression among the indicated population of thymic <italic>i</italic>NKT cells. <bold>(C)</bold> IL-2R&#x3b2; expression in GFP<sup>+</sup> and GFP-negative mature <italic>i</italic>NKT cells of <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> <italic>i</italic>NKT mice. Bar graphs show the summary of analyzing 6 <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> mice. <bold>(D)</bold> GFP expression in ST1, ST2, and ST3 <italic>i</italic>NKT cells of <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> and littermate control thymocytes. The data are representative of 4 independent experiments. <bold>(E)</bold> Thymic <italic>i</italic>NKT cell differentiation in <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> mice. <italic>i</italic>NKT cells were stained for CD44 and NK1.1 to identify ST1, ST2, and ST3 cells as shown in the contour plots (top). The bar graph shows the frequencies of ST1, ST2, and ST3 cells in GFP<sup>+</sup> and GFP<sup>&#x2013;</sup> thymic <italic>i</italic>NKT cells of <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> mice (bottom). Results show the summary of 6 independent experiments with a total of 14 <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> mice. <bold>(F)</bold> Bcl-2 expression in GFP<sup>+</sup> and GFP<sup>&#x2013;</sup> <italic>i</italic>NKT cells of <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> thymocytes. Histograms are representative (left), and the bar graph (right) shows the summary of 3 independent experiments with a total of 8 <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> mice. **P &lt; 0.01; ***P &lt; 0.001. NS, Not Significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-642856-g002.tif"/>
</fig>
<p>To understand these results, we considered two possibilities. Firstly, IL-2R&#x3b2; expression in the thymus could be dispensable for <italic>i</italic>NKT cell generation. Alternatively, the PLZF-Cre-mediated deletion of IL-2R&#x3b2; could be incomplete. In the latter case, the variegated expression of the PLZF-Cre or inefficient excision of the floxed allele could result in the retention of IL-2R&#x3b2; expression. To discriminate these possibilities, it would be necessary to monitor the deletion efficiency of IL-2R&#x3b2; in <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> mice. Notably, the <italic>Il2rb</italic>-floxed allele (<italic>Il2rb</italic>
<sup>fl</sup>) is engineered to induce the expression of Green Fluorescent Proteins (GFP) upon IL-2R&#x3b2; deletion (<xref ref-type="bibr" rid="B21">21</xref>), permitting the identification of <italic>i</italic>NKT cells that have deleted IL-2R&#x3b2;. Employing this feature, we next analyzed the efficiency of IL-2R&#x3b2; deletion by assessing GFP expression. Among HSA<sup>hi</sup> immature <italic>i</italic>NKT cells (ST0), GFP was only found in a very small fraction of <italic>i</italic>NKT cells (<xref ref-type="fig" rid="f2">
<bold>Figure 2B</bold>
</xref>, top histogram). Among HSA<sup>lo</sup> <italic>i</italic>NKT cells, however, a large fraction of cells turned out to be GFP<sup>+</sup>, reporting the successful deletion of the <italic>Il2rb</italic>
<sup>fl</sup> allele in mature <italic>i</italic>NKT cells (<xref ref-type="fig" rid="f2">
<bold>Figure 2B</bold>
</xref>, bottom histogram, and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 3B</bold>
</xref>). Assessing the surface IL-2R&#x3b2; expression on GFP<sup>+</sup> and GFP-negative mature <italic>i</italic>NKT cells showed a substantial loss of surface IL-2R&#x3b2; on GFP<sup>+</sup> cells (<xref ref-type="fig" rid="f2">
<bold>Figure 2C</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 3C</bold>
</xref>). Thus, GFP<sup>+</sup> cells correspond to <italic>i</italic>NKT cells that have terminated IL-2R&#x3b2; expression. Importantly, the frequencies of such GFP<sup>+</sup> <italic>i</italic>NKT cells increased upon their further differentiation into ST1, ST2, and ST3 <italic>i</italic>NKT cells (<xref ref-type="fig" rid="f2">
<bold>Figure 2D</bold>
</xref>). These results suggested that PLZF<sup>Cre</sup>- mediated deletion of IL-2R&#x3b2; is initiated in ST0 cells but not accomplished until later stages of <italic>i</italic>NKT cell development. Because of this delayed deletion, significant amounts of surface IL-2R&#x3b2; remained on GFP<sup>+</sup> <italic>i</italic>NKT cells which could provide residual IL-2R signaling (<xref ref-type="fig" rid="f2">
<bold>Figure 2C</bold>
</xref>). Along these lines, we noted that a significant fraction of HSA<sup>lo</sup> mature <italic>i</italic>NKT cells remained GFP-negative and fully expressed IL-2R&#x3b2; (<xref ref-type="fig" rid="f2">
<bold>Figure 2B</bold>
</xref> bottom). Such inefficient deletion could explain why we did not find significant differences in the frequency and number of thymic <italic>i</italic>NKT cells between <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> and littermate control mice (<xref ref-type="fig" rid="f2">
<bold>Figure 2A</bold>
</xref>). We also did not find any significant changes in the ST1-ST3 distribution of GFP<sup>+</sup> <italic>i</italic>NKT cells which expressed dramatically lower amounts of IL-2R&#x3b2; compared to GFP-negative <italic>i</italic>NKT cells (<xref ref-type="fig" rid="f2">
<bold>Figure 2E</bold>
</xref>). We also did not find differences in the ST1-3 distribution of <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> mice compared to <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>WT</sup> littermates that express normal amounts of IL-2R&#x3b2; (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 3D</bold>
</xref>). Along these lines, the thymic <italic>i</italic>NKT subset composition and the frequency of T-bet<sup>+</sup> <italic>i</italic>NKT cells which correspond to ST3 cells were virtually unaltered in <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> mice (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures 4A, B</bold>
</xref>). On the other hand, the protein abundance of Bcl-2, a direct downstream molecule of IL-2R&#x3b2; signaling (<xref ref-type="bibr" rid="B31">31</xref>), was markedly diminished (<xref ref-type="fig" rid="f2">
<bold>Figure 2F</bold>
</xref>), indicating that the lack of IL-2R&#x3b2; had physiological consequences for <italic>i</italic>NKT cells. Nonetheless, the survival of GFP<sup>+</sup> thymic <italic>i</italic>NKT cells remained unaffected, because Bcl-xL and not Bcl-2 provides pro-survival signals for <italic>i</italic>NKT cells (<xref ref-type="bibr" rid="B11">11</xref>). In agreement the frequency and number as well as the subset composition of iNKT cells in the spleen did not differ between <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> and <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>WT</sup> mice (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 4C</bold>
</xref>). Collectively, the undisturbed differentiation of GFP<sup>+</sup> <italic>i</italic>NKT cells in <italic>Il2rb</italic>
<sup>fl/fl</sup>PLZF<sup>Cre</sup> mice suggested that the late-stage deletion of IL-2R&#x3b2; is not detrimental for the ST1 to ST3 <italic>i</italic>NKT cell maturation.</p>
</sec>
<sec id="s3_3">
<title>IL-2R&#x3b2; Is Critical for the Generation of Thymic <italic>i</italic>NKT Cells</title>
<p>To further delineate the role of IL-2R&#x3b2; in the generation and differentiation of <italic>i</italic>NKT cells, we next analyzed the development and subset composition of thymic <italic>i</italic>NKT cells in germline IL-2R&#x3b2;-deficient (<italic>Il2rb</italic>
<sup>&#x2013;/&#x2013;</sup>) mice (<xref ref-type="bibr" rid="B22">22</xref>). In <italic>Il2rb</italic>
<sup>&#x2013;/&#x2013;</sup> mice, all thymocytes - including ST0 immature <italic>i</italic>NKT cells - are devoid of IL-2R&#x3b2;. Thus, an IL-2R&#x3b2; requirement for <italic>i</italic>NKT cells can be assessed starting at the earliest precursor stages of <italic>i</italic>NKT cell development. Notably, <italic>Il2rb</italic>
<sup>&#x2013;/&#x2013;</sup> mice are autoimmune because of the impaired generation of immunosuppressive Foxp3<sup>+</sup> Treg cells that require IL-2 signaling for their maturation (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>). Consequently, we analyzed <italic>Il2rb</italic>
<sup>&#x2013;/&#x2013;</sup> mice before 6 weeks of age to avoid the potential skewing of <italic>i</italic>NKT cell differentiation due to autoimmunity. We confirmed that the thymus of <italic>Il2rb</italic>
<sup>&#x2013;/&#x2013;</sup> mice at that age did not show an overtly activated phenotype, and that T cell development remained comparable to that of WT littermate mice (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 5A</bold>
</xref>). We further confirmed the lack of <italic>in vivo</italic> IL-2R&#x3b2; signaling in <italic>Il2rb</italic>
<sup>&#x2013;/&#x2013;</sup> mice by their absence of mature CD25<sup>+</sup>Foxp3<sup>+</sup> Treg cells which require IL-2R signaling for their generation (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 5B</bold>
</xref>) (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>). Consistent with previous reports (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>), we confirmed a dramatic reduction in the frequency and number of thymic <italic>i</italic>NKT cells of <italic>Il2rb</italic>
<sup>&#x2013;/&#x2013;</sup> mice compared with those of WT littermate mice (<xref ref-type="fig" rid="f3">
<bold>Figure 3A</bold>
</xref>). Notably, the loss was specific for <italic>i</italic>NKT cells and did not affect conventional &#x3b1;&#x3b2; T cells, resulting in a dramatically decreased ratio of <italic>i</italic>NKT cells over &#x3b1;&#x3b2; T cells (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 5C</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure 3</label>
<caption>
<p>An IL-2R&#x3b2; requirement for thymic <italic>i</italic>NKT cell differentiation <bold>(A)</bold> Frequency and number of thymic <italic>i</italic>NKT cells in <italic>Il2rb</italic>
<sup>&#x2013;/&#x2013;</sup> and WT littermate mice. Dot plots show thymic <italic>i</italic>NKT cells as identified by CD1dTet and TCR&#x3b2; staining. Total thymocyte numbers are shown above the dot plots as the means &#xb1; SEM (left). Bar graphs show the frequencies and numbers of <italic>i</italic>NKT cells from the indicated mice (right). The dot plot is representative, and the bar graphs are a summary of 4 independent experiments with a total of 13 <italic>Il2rb</italic>
<sup>&#x2013;/&#x2013;</sup> and 7 WT littermate mice. <bold>(B)</bold> Thymic <italic>i</italic>NKT cell differentiation in <italic>Il2rb</italic>
<sup>&#x2013;/&#x2013;</sup> mice. HSA<sup>lo</sup> mature <italic>i</italic>NKT cells were stained for CD44 and NK1.1 to identify ST1, ST2, and ST3 cells in the indicated mice (left). The bar graph shows the frequencies of ST1, ST2, and ST3 cells in <italic>Il2rb</italic>
<sup>&#x2013;/&#x2013;</sup> and WT littermate mice (right). The dot and contour plots are representative, and the bar graph shows the summary of 4 independent experiments. <bold>(C)</bold> Dot plots show the thymic <italic>i</italic>NKT subset composition in <italic>Il2rb</italic>
<sup>&#x2013;/&#x2013;</sup> and WT littermate mice (left). The bar graph on top shows the frequency of thymic <italic>i</italic>NKT subsets as summary of 5 independent experiments with a total of 14 <italic>Il2rb</italic>
<sup>&#x2013;/&#x2013;</sup> and 8 WT littermate mice. The bottom bar graph shows the cell numbers of thymic <italic>i</italic>NKT subsets as the summary of 4 independent experiments with a total of 9 <italic>Il2rb</italic>
<sup>&#x2013;/&#x2013;</sup> and 4 WT littermate control mice. *P &lt; 0.05; **P &lt; 0.01; ***P &lt; 0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-642856-g003.tif"/>
</fig>
<p>Most thymic <italic>i</italic>NKT cells in C57BL/6 background mice correspond to ST3 cells. Therefore, we expected that IL-2R&#x3b2;-deficiency would selectively affect the differentiation of ST3 <italic>i</italic>NKT cells. Indeed, <italic>Il2rb</italic>
<sup>&#x2013;/&#x2013;</sup> thymic <italic>i</italic>NKT cells were developmentally arrested, resulting in the accumulation of ST1/ST2 <italic>i</italic>NKT cells and in a substantial decrease in ST3 <italic>i</italic>NKT cells (<xref ref-type="fig" rid="f3">
<bold>Figure 3B</bold>
</xref>). We further found that the fraction of NKT1 cells was significantly diminished among <italic>Il2rb</italic>
<sup>&#x2013;/&#x2013;</sup> <italic>i</italic>NKT cells, which in turn resulted in the relative overrepresentation of NKT2 and NKT17 cells (<xref ref-type="fig" rid="f3">
<bold>Figure 3C</bold>
</xref>). The <italic>i</italic>NKT cell number for each subset, however, were significantly reduced (<xref ref-type="fig" rid="f3">
<bold>Figure 3C</bold>
</xref>), which was consistent with the dramatic decrease in total <italic>i</italic>NKT cell numbers in <italic>Il2rb</italic>
<sup>&#x2013;/&#x2013;</sup> mice (<xref ref-type="fig" rid="f3">
<bold>Figure 3A</bold>
</xref>). Collectively, these results from <italic>Il2rb</italic>
<sup>&#x2013;/&#x2013;</sup> mice documented a major role for the cytokine receptor IL-2R&#x3b2; in the generation, but also in the subset differentiation of thymic <italic>i</italic>NKT cells.</p>
</sec>
<sec id="s3_4">
<title>Forced Expression of IL-2R&#x3b2; Suppresses <italic>i</italic>NKT Cell Development in the Thymus</title>
<p>Because IL-2R&#x3b2; is important for NKT1 cell generation (<xref ref-type="fig" rid="f3">
<bold>Figure 3C</bold>
</xref>), we next asked whether IL-2R&#x3b2; would be also sufficient to impose NKT1 lineage fate during <italic>i</italic>NKT cell development. To this end, we assessed <italic>i</italic>NKT cell development in IL-2R&#x3b2;-transgenic mice (IL-2R&#x3b2;<sup>Tg</sup>) that overexpress mouse IL-2R&#x3b2; under the control of human <italic>CD2</italic> promoter/enhancer elements (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B34">34</xref>). In these animals, the transgenic IL-2R&#x3b2; is prematurely expressed on preselection thymocytes (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 6A</bold>
</xref>) and further overexpressed on postselection mature T cells (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 6A</bold>
</xref>). Consequently, the IL-2R&#x3b2; is abundantly expressed on both immature and mature thymocytes of IL-2R&#x3b2;<sup>Tg</sup> mice. Among <italic>i</italic>NKT cells, immature HSA<sup>hi</sup>CD44<sup>&#x2013;</sup> <italic>i</italic>NKT cells (ST0) normally do not express IL-2R&#x3b2; (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 6B</bold>
</xref>). However, the ST0 <italic>i</italic>NKT cells in IL-2R&#x3b2;<sup>Tg</sup> mice displayed substantially increased abundance of IL-2R&#x3b2; (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 6B</bold>
</xref>). Importantly, such premature expression of IL-2R&#x3b2; dramatically impaired the generation of <italic>i</italic>NKT cells, so that the frequency and number of thymic <italic>i</italic>NKT cells in IL-2R&#x3b2;<sup>Tg</sup> mice were markedly reduced (<xref ref-type="fig" rid="f4">
<bold>Figure 4A</bold>
</xref>). These results suggested that IL-2 receptor signaling in immature <italic>i</italic>NKT is detrimental to the generation of thymic <italic>i</italic>NKT cells. These findings also indicated that the timing of IL-2R&#x3b2; expression during <italic>i</italic>NKT cell development needs to be carefully controlled, presumably to protect immature <italic>i</italic>NKT cells from premature IL-2 or IL-15 signaling.</p>
<fig id="f4" position="float">
<label>Figure 4</label>
<caption>
<p>
<italic>i</italic>NKT cell differentiation in IL-2R&#x3b2; transgenic mice <bold>(A)</bold> Frequency and number of thymic <italic>i</italic>NKT cells in IL-2R&#x3b2;<sup>Tg</sup> and littermate C57BL/6 mice. The dot plots show thymic <italic>i</italic>NKT cells as identified by CD1dTet <italic>versus</italic> TCR&#x3b2; staining (left). The total thymocyte numbers are shown above the dot plots as the means &#xb1; SEM. The bar graphs show the frequencies and numbers of <italic>i</italic>NKT cells from the indicated mice (right). The dot plot is representative, and the bar graphs are a summary of 4 independent experiments with a total of 7 IL-2R&#x3b2;<sup>Tg</sup> and 6 littermate C57BL/6 mice. <bold>(B)</bold> Frequency and number of thymic <italic>i</italic>NKT cells in IL-2R&#x3b2;<sup>Tg</sup> BALB/c and littermate WT mice. The dot plots show thymic <italic>i</italic>NKT cells as identified by CD1dTet <italic>versus</italic> TCR&#x3b2; staining (left). The total thymocyte numbers are shown above the dot plots as the means &#xb1; SEM. The bar graphs show the frequencies and numbers of <italic>i</italic>NKT cells from the indicated mice (right). The dot plot is representative, and the bar graphs are a summary of 3 independent experiments with a total of 7 IL-2R&#x3b2;<sup>Tg</sup> and 8 littermate WT mice. <bold>(C)</bold> The dot plots show the thymic <italic>i</italic>NKT subset composition in IL-2R&#x3b2;<sup>Tg</sup> BALB/c and WT littermate mice based on PLZF <italic>versus</italic> T-bet (top) and PLZF <italic>versus</italic> ROR&#x3b3;t analysis (bottom). Results are representative of 4 independent experiments. <bold>(D)</bold> The bar graphs show the summary of thymic <italic>i</italic>NKT subset distribution for the indicated mice. Subset frequencies are the summary of 5 independent experiments with a total of 10 IL-2R&#x3b2;<sup>Tg</sup> and 10 littermate WT BALB/c mice (top). Cell numbers of each <italic>i</italic>NKT subset are the summary of 4 independent experiments with a total of 8 IL-2R&#x3b2;<sup>Tg</sup> and 7 littermate WT BALB/c control mice (bottom). *P &lt; 0.05; **P &lt; 0.01; ***P &lt; 0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-642856-g004.tif"/>
</fig>
</sec>
<sec id="s3_5">
<title>Forced Expression of IL-2R&#x3b2; Suppresses the Generation of NKT1 Cells in BALB/c Mice</title>
<p>Because IL-2R&#x3b2; is associated with NKT1 cell differentiation, we next aimed to interrogate if premature IL-2R&#x3b2; expression in immature ST0 <italic>i</italic>NKT cells would affect the development of other <italic>i</italic>NKT subsets. In C57BL/6 mice, most thymic <italic>i</italic>NKT cells correspond to NKT1 cells (<xref ref-type="bibr" rid="B10">10</xref>), making it difficult to discern how the IL-2R&#x3b2;<sup>Tg</sup> would affect NKT2 and NKT17 cells which are underrepresented in this mouse strain. BALB/c mice differ from C57BL/6 mice in their thymic <italic>i</italic>NKT subset composition as it is enriched in NKT2 and NKT17 cells and reduced in NKT1 cells compared with that in C57BL/6 mice (<xref ref-type="bibr" rid="B10">10</xref>). Thus, we considered BALB/c mice as an appropriate model to assess the effects of premature IL-2R&#x3b2; expression on NKT2 and NKT17 cell generation. To this end, we backcrossed the IL-2R&#x3b2;<sup>Tg</sup> onto the BALB/c background and analyzed the development and differentiation of thymic <italic>i</italic>NKT cells in these mice.</p>
<p>As expected, the thymocytes of IL-2R&#x3b2;<sup>Tg</sup> BALB/c mice expressed substantially increased amounts of surface IL-2R&#x3b2; compared with the thymocytes of littermate mice (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 6C</bold>
</xref>). Such increase in the IL-2R&#x3b2; abundance was also observed in HSA<sup>hi</sup>CD44<sup>&#x2013;</sup> (ST0) immature <italic>i</italic>NKT cells (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 6D</bold>
</xref>), but curiously not in HSA<sup>lo</sup> mature <italic>i</italic>NKT cells (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 6D</bold>
</xref>). These results suggested that the expression of the IL-2R&#x3b2;<sup>Tg</sup> is either silenced in HSA<sup>lo</sup> <italic>i</italic>NKT cells or that the premature expression of IL-2R&#x3b2; in HSA<sup>hi</sup>CD44<sup>&#x2013;</sup> (ST0) immature <italic>i</italic>NKT cells is detrimental for <italic>i</italic>NKT cell generation so that only <italic>i</italic>NKT cells that have escaped the transgene expression can mature. In fact, we found that the frequency and number of thymic <italic>i</italic>NKT cells were indeed dramatically reduced in IL-2R&#x3b2;<sup>Tg</sup> BALB/c mice (<xref ref-type="fig" rid="f4">
<bold>Figure 4B</bold>
</xref>). Thus, consistent with our findings in IL-2R&#x3b2;<sup>Tg</sup> C57BL/6 mice (<xref ref-type="fig" rid="f4">
<bold>Figure 4A</bold>
</xref>), the forced expression of IL-2R&#x3b2; suppresses the generation of thymic <italic>i</italic>NKT cells in BALB/c mice also (<xref ref-type="fig" rid="f4">
<bold>Figure 4B</bold>
</xref>).</p>
<p>To understand the effects of IL-2R&#x3b2; on <italic>i</italic>NKT cell differentiation, we next examined the <italic>i</italic>NKT subset composition in IL-2R&#x3b2;<sup>Tg</sup> BALB/c mice. Surprisingly, NKT1 cells, as identified by T-bet expression, were virtually absent in IL-2R&#x3b2;<sup>Tg</sup> BALB/c thymocytes. Both the frequency and number of T-bet<sup>+</sup> NKT1 cells were dramatically decreased in these mice (<xref ref-type="fig" rid="f4">
<bold>Figures 4C, D</bold>
</xref>). Conversely, NKT2 and NKT17 cell frequencies were significantly increased in IL-2R&#x3b2;<sup>Tg</sup> BALB/c mice compared with those of WT littermate controls (<xref ref-type="fig" rid="f4">
<bold>Figures 4C, D</bold>
</xref>). Thus, transgenic IL-2R&#x3b2; selectively inhibited the development of NKT1 cells without suppressing the generation of NKT2 and NKT17 cells.</p>
<p>To further examine how IL-2R&#x3b2;<sup>Tg</sup> would interfere with the induction of T-bet and impair NKT1 cell generation, we employed the T-bet-ZsGreen reporter mouse (TBGR<sup>Tg</sup>) to monitor T-bet transcription in IL-2R&#x3b2;<sup>Tg</sup> and WT BALB/c mice (<xref ref-type="fig" rid="f5">
<bold>Figure 5A</bold>
</xref>) (<xref ref-type="bibr" rid="B25">25</xref>). The TBGR<sup>Tg</sup> is designed to express ZsGreen reporter proteins from the <italic>Tbx21</italic> gene locus which encodes for T-bet so that ZsGreen expression reflects <italic>Tbx21</italic> transcription (<xref ref-type="bibr" rid="B25">25</xref>). Indeed, we identified a substantial population of ZsGreen<sup>+</sup> cells among thymic <italic>i</italic>NKT cells of TBGR<sup>Tg</sup> BALB/c mice (<xref ref-type="fig" rid="f5">
<bold>Figure 5A</bold>
</xref>), and these ZsGreen<sup>+</sup> <italic>i</italic>NKT cells corresponded to NKT1 cells based on their intracellular PLZF and T-bet protein expression (<xref ref-type="fig" rid="f5">
<bold>Figure 5B</bold>
</xref>, left). In contrast, TBGR<sup>Tg</sup> IL-2R&#x3b2;<sup>Tg</sup> BALB/c failed to generate ZsGreen<sup>+</sup>T-bet<sup>+</sup> <italic>i</italic>NKT cells (<xref ref-type="fig" rid="f5">
<bold>Figure 5B</bold>
</xref>, right), affirming the detrimental effect of IL-2R&#x3b2;<sup>Tg</sup> on NKT1 cell generation.</p>
<fig id="f5" position="float">
<label>Figure 5</label>
<caption>
<p>T-bet-ZsGreen reporter expression in <italic>i</italic>NKT cells of IL-2R&#x3b2;<sup>Tg</sup> BALB/c mice <bold>(A)</bold> Thymic <italic>i</italic>NKT cells were identified in BALB/c and TBGR<sup>Tg</sup> BALB/c mice (top) and assessed for T-bet-ZsGreen reporter expression (bottom). Results are representative of 5 independent experiments. <bold>(B)</bold> T-bet-ZsGreen reporter expression in thymic <italic>i</italic>NKT cells of TBGR<sup>Tg</sup>IL-2R&#x3b2;<sup>Tg</sup> BALB/c and TBGR<sup>Tg</sup> littermate control mice. Dot plots show either PLZF <italic>versus</italic> T-bet-ZsGreen reporter expression (top) or T-bet protein <italic>versus</italic> T-bet-ZsGreen reporter expression (bottom) in HSA<sup>lo</sup> thymic <italic>i</italic>NKT cells of TBGR<sup>Tg</sup> IL-2R&#x3b2;<sup>Tg</sup> BALB/c and TBGR<sup>Tg</sup> WT littermate mice. Bar graph shows the frequency of T-bet-ZsGreen<sup>+</sup> <italic>i</italic>NKT cells (red box) of the indicated mice. Results are representative 3 independent experiments with 8 TBGR<sup>Tg</sup>IL-2R&#x3b2;<sup>Tg</sup> BALB/c and 5 TBGR<sup>Tg</sup> littermate WT BALB/c mice. <bold>(C)</bold> T-bet-ZsGreen reporter expression upon NKT1 cell differentiation. Thymic <italic>i</italic>NKT cells of TBGR<sup>Tg</sup> BALB/c mice were divided into three distinct populations, <italic>i.e.</italic> I, II, and III, based on the amount of T-bet-ZsGreen expression (dot plot, left). Surface expression of CD44, IL-2R&#x3b2;, and TCR&#x3b2; was then assessed for each <italic>i</italic>NKT population (histograms, right). Results are representative of 2 independent experiments with a total of 6 TBGR<sup>Tg</sup> BALB/c mice. <bold>(D)</bold> Subset compositions of thymic <italic>i</italic>NKT cells in TBGR<sup>Tg</sup> BALB/c mice based on ZsGreen-reporter expression. Total <italic>i</italic>NKT cells, T-bet-ZsGreen-negative (population I), and T-bet-ZsGreen-intermediate (population II) <italic>i</italic>NKT cells were identified in TBGR<sup>Tg</sup> WT BALB/c (top) and TBGR<sup>Tg</sup>IL-2R&#x3b2;<sup>Tg</sup> BALB/c thymocytes (bottom) and examined for their subset composition based on PLZF <italic>versus</italic> ROR&#x3b3;t staining. Results are representative of 3 independent experiments with 8 TBGR<sup>Tg</sup>IL-2R&#x3b2;<sup>Tg</sup> BALB/c and 5 TBGR<sup>Tg</sup> littermate WT BALB/c mice. **P &lt; 0.01.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-642856-g005.tif"/>
</fig>
<p>Of note, we found in both WT and IL-2R&#x3b2;<sup>Tg</sup> thymocytes a distinct population of <italic>i</italic>NKT cells with intermediate amounts of ZsGreen and T-bet expression, <italic>i.e.</italic> ZsGreen<sup>int</sup>T-bet<sup>int</sup> (<xref ref-type="fig" rid="f5">
<bold>Figure 5B</bold>
</xref>, cells gated in blue), whose developmental status was unclear to us. To further characterize these ZsGreen<sup>int</sup>T-bet<sup>int</sup> <italic>i</italic>NKT cells, we divided TBGR<sup>Tg</sup> BALB/c <italic>i</italic>NKT cells into 3 populations, <italic>i.e.</italic> I, II, and III, based on their progressive increase in ZsGreen reporter expression. Accordingly, the ZsGreen<sup>int</sup>T-bet<sup>int</sup> cells corresponded to population II, while ZsGreen<sup>hi</sup>T-bet<sup>hi</sup> cells were defined as population III (<xref ref-type="fig" rid="f5">
<bold>Figure 5C</bold>
</xref>). Thymic <italic>i</italic>NKT cells that did not express ZsGreen were referred to as population I. Terminally differentiated NKT1 cells, as identified as population III, expressed large amounts of T-bet and CD44 (<xref ref-type="fig" rid="f5">
<bold>Figure 5C</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 6E</bold>
</xref>) (<xref ref-type="bibr" rid="B11">11</xref>). ZsGreen<sup>int</sup>T-bet<sup>int</sup> cells (population II), on the other hand, expressed significantly smaller amounts of T-bet and CD44 but showed greater abundance of TCR&#x3b2;. Importantly, ZsGreen<sup>int</sup>T-bet<sup>int</sup> cells had not yet induced CD122 expression, suggesting that they are NKT1-lineage committed but not fully differentiated NKT1 cells (<xref ref-type="fig" rid="f5">
<bold>Figures 5C, D</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 6E</bold>
</xref>) (<xref ref-type="bibr" rid="B35">35</xref>). Along these lines, the ZsGreen<sup>int</sup>T-bet<sup>int</sup> population did not contain ROR&#x3b3;t<sup>+</sup> <italic>i</italic>NKT cells (<xref ref-type="fig" rid="f5">
<bold>Figure 5D</bold>
</xref>), indicating that NKT17 cell differentiation is branched off before the appearance of ZsGreen<sup>int</sup>T-bet<sup>int</sup> population II <italic>i</italic>NKT cells. Thus, we identified a new subpopulation of thymic <italic>i</italic>NKT cells, <italic>i.e.</italic> ZsGreen<sup>int</sup>T-bet<sup>int</sup> <italic>i</italic>NKT cells, that are NKT1-lineage committed but are not fully differentiated into mature NKT1 cells. Because ZsGreen<sup>+</sup>T-bet<sup>+</sup> <italic>i</italic>NKT cells were missing in IL-2R&#x3b2;<sup>Tg</sup> thymocytes, these results further suggest that the forced and premature expression of IL-2R&#x3b2; interferes with the terminal differentiation of T-bet<sup>+</sup> NKT1 cells but did not inhibit the induction of T-bet expression itself. Collectively, these results unveil an unexpected negative effect of IL-2R&#x3b2; on <italic>i</italic>NKT subset differentiation.</p>
</sec>
<sec id="s3_6">
<title>Thymic <italic>i</italic>NKT Cell Differentiation in IL-15-Infused IL-2R&#x3b2;<sup>Tg</sup> BALB/c Mice</title>
<p>To understand how IL-2R&#x3b2; overexpression would affect thymic <italic>i</italic>NKT cell generation, we considered two alternative but not mutually exclusive hypotheses. First, the increased abundance of IL-2R&#x3b2; proteins in IL-2R&#x3b2;<sup>Tg</sup> mice could increase the binding and consumption of IL-15, thus diminishing the availability of IL-15 for <italic>i</italic>NKT cell development. IL-15 is critical for the generation of <italic>i</italic>NKT cells in general and specifically for NKT1 cells (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B36">36</xref>). Consequently, the detrimental effect of IL-2R&#x3b2;<sup>Tg</sup> on <italic>i</italic>NKT cells could have been due to insufficient IL-15 availability, partly phenocopying the effect of IL-15-deficiency (<xref ref-type="bibr" rid="B37">37</xref>). In a second scenario, we focused on the timing of IL-2R&#x3b2; expression. IL-2R&#x3b2; is normally not induced in immature <italic>i</italic>NKT cells but forcibly expressed in IL-2R&#x3b2;<sup>Tg</sup> mice. Premature IL-2R&#x3b2; signaling could interfere with <italic>i</italic>NKT cell generation and specifically with NKT1 cell differentiation, albeit the molecular mechanism would be unclear. To discriminate between these possibilities, we implanted IL-2R&#x3b2;<sup>Tg</sup> mice with osmotic pumps that release recombinant IL-15 to supply excess amounts of IL-15 <italic>in vivo</italic> (<xref ref-type="fig" rid="f6">
<bold>Figure 6A</bold>
</xref>). After 10 days of IL-15 pump installation in IL-2R&#x3b2;<sup>Tg</sup> mice, we found a dramatic increase in spleen size and increased frequencies of NK cells whose maintenance depends on IL-15 (<xref ref-type="bibr" rid="B38">38</xref>) (<xref ref-type="fig" rid="f6">
<bold>Figure 6A</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 7A</bold>
</xref>). Moreover, the frequency of CD8 T cells and specifically the number of CD44<sup>hi</sup> CXCR3<sup>+</sup> memory-phenotype CD8 T cells were substantially increased in mice that were implanted with IL-15- but not with PBS-releasing pumps (<xref ref-type="fig" rid="f6">
<bold>Figure 6A</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 7B</bold>
</xref>
<bold>)</bold>. These results were consistent with the effects of increased IL-15 availability <italic>in vivo</italic> (<xref ref-type="bibr" rid="B39">39</xref>). The generation of thymic <italic>i</italic>NKT cells in IL-2R&#x3b2;<sup>Tg</sup> BALB/c mice, however, remained unaffected by the IL-15 infusion (<xref ref-type="fig" rid="f6">
<bold>Figure 6B</bold>
</xref>), and the <italic>i</italic>NKT subset composition also remained unaltered (<xref ref-type="fig" rid="f6">
<bold>Figures 6C, D</bold>
</xref>). Thus, despite supplemented with excess amounts of IL-15, the IL-2R&#x3b2;<sup>Tg</sup> mice were still impaired in thymic <italic>i</italic>NKT cell differentiation, with both dramatically reduced frequencies and numbers of NKT1 cells (<xref ref-type="fig" rid="f6">
<bold>Figures 6C, D</bold>
</xref>). Along these lines, the thymic generation of Foxp3<sup>+</sup> Treg cells which depend on IL-2 and IL-2 receptor signaling (<xref ref-type="bibr" rid="B33">33</xref>) was unaffected in IL-2R&#x3b2;<sup>Tg</sup> mice (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 7C</bold>
</xref>), which further supports that the availability of intrathymic cytokines remains unaltered by IL-2R&#x3b2; overexpression. Altogether, these results suggested that it is unlikely that increased consumption and reduced availability of <italic>in vivo</italic> IL-15 would account for the lack of NKT1 cells in IL-2R&#x3b2;<sup>Tg</sup> mice.</p>
<fig id="f6" position="float">
<label>Figure 6</label>
<caption>
<p>Thymic <italic>i</italic>NKT cell differentiation in IL-15-infused IL-2R&#x3b2;<sup>Tg</sup> BALB/c mice <bold>(A)</bold> Effects of recombinant IL-15- or PBS-releasing Alzet osmotic pump installation on IL-2R&#x3b2;<sup>Tg</sup> BALB/c mice. Spleen CD8 T cells of IL-2R&#x3b2;<sup>Tg</sup> BALB/c mice that were infused with IL-15 or PBS for 10 days were assessed for the accumulation of memory-phenotype CD8 T cells by CD44 <italic>versus</italic> CXCR3 staining. Frequency and numbers of CD44<sup>hi</sup>CXCR3<sup>+</sup> CD8 T cells are representative of 2 independent experiments with 4 IL-15 pump and 3 PBS pump implanted IL-2R&#x3b2;<sup>Tg</sup> BALB/c mice (top). Picture shows spleens of IL-2R&#x3b2;<sup>Tg</sup> BALB/c mice that were implanted with PBS or IL-15 Alzet pumps (bottom). Scale bar = 1&#xa0;cm. <bold>(B)</bold> Frequencies and numbers of thymic <italic>i</italic>NKT cells of IL-2R&#x3b2;<sup>Tg</sup> BALB/c mice implanted with IL-15- or PBS-releasing Alzet osmotic pumps. Dot plots are representative (top) and graphs are summary (bottom) of 3 independent experiments with a total of 5 IL-15 pump and 4 PBS pump implanted IL-2R&#x3b2;<sup>Tg</sup> BALB/c mice. <bold>(C)</bold> Thymic <italic>i</italic>NKT subset composition IL-2R&#x3b2;<sup>Tg</sup> BALB/c implanted with IL-15 or PBS-releasing Alzet osmotic pumps. NKT1 cells were identified by PLZF <italic>versus</italic> T-bet of HSA<sup>lo</sup> mature thymic <italic>i</italic>NKT cells. Results are representative of 3 independent experiments with 5 IL-15 pump and 4 PBS pump implanted IL-2R&#x3b2;<sup>Tg</sup> BALB/c mice. <bold>(D)</bold> Frequencies and numbers of NKT1 cells in IL-2R&#x3b2;<sup>Tg</sup> BALB/c implanted with IL-15 or PBS-releasing Alzet osmotic pumps. Results are summary of 3 independent experiments with 5 IL-15 pump and 4 PBS pump implanted IL-2R&#x3b2;<sup>Tg</sup> BALB/c mice. <bold>(E)</bold> Frequency of thymic <italic>i</italic>NKT cells in CA-STAT5<sup>Tg</sup> and littermate C57BL/6 mice. The dot plots show thymic <italic>i</italic>NKT cells as identified by CD1dTet <italic>versus</italic> TCR&#x3b2; staining (left). The total thymocyte numbers are shown above the dot plots as the means &#xb1; SEM (left). The bar graph shows the frequency of <italic>i</italic>NKT cells from the indicated mice (right). The dot plot is representative, and the bar graphs are a summary of 4 independent experiments with a total of 7 CA-STAT5<sup>Tg</sup> and 8 littermate WT mice <bold>(F)</bold> Cell numbers of DP thymocytes and thymic NKT1 cells from CA-STAT5<sup>Tg</sup> and littermate WT C57BL/6 mice. Bar graph shows the summary from a total of 7 CA-STAT5<sup>Tg</sup> and 5 littermate WT mice. *P &lt; 0.05; **P &lt; 0.01. NS, Not Significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-642856-g006.tif"/>
</fig>
</sec>
<sec id="s3_7">
<title>Constitutively Active STAT5 Suppresses the Development of Thymic <italic>i</italic>NKT Cells</title>
<p>To gain further mechanistic insights into whether and how premature IL-2R&#x3b2; expression would impair <italic>i</italic>NKT cell generation, we considered that STAT5 phosphorylation is a major downstream event of IL-2R&#x3b2; signaling (<xref ref-type="bibr" rid="B40">40</xref>). The transcription factor STAT5 plays a critical role in T cell development as it induces the expression of prosurvival molecules, such as Bcl-2, and controls the activity of several key transcription factors in T cell differentiation (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>). Because immature ST0 <italic>i</italic>NKT cells lack IL-2R&#x3b2; (<xref ref-type="fig" rid="f1">
<bold>Figure 1C</bold>
</xref>), we postulated that ST0 <italic>i</italic>NKT cells of WT mice would not induce phospho-STAT5 (pSTAT5) upon IL-15 stimulation. ST0 <italic>i</italic>NKT cells in IL-2R&#x3b2;<sup>Tg</sup> mice, on the other hand, would have induced substantial amounts of pSTAT5 due the premature expression and signaling of IL-2R&#x3b2;.</p>
<p>If it would be the premature STAT5 activation which suppresses <italic>i</italic>NKT cell generation, we hypothesized that a constitutively active STAT5b transgene (CA-STAT5<sup>Tg</sup>) would also impair <italic>i</italic>NKT cell generation (<xref ref-type="bibr" rid="B24">24</xref>). Indeed, we found that both the frequency and number of thymic <italic>i</italic>NKT cells were dramatically reduced in CA-STAT5<sup>Tg</sup> mice compared to those in WT littermate controls (<xref ref-type="fig" rid="f6">
<bold>Figure 6E</bold>
</xref>). Moreover, assessing the composition of thymic <italic>i</italic>NKT subsets in CA-STAT5<sup>Tg</sup> mice (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 8A</bold>
</xref>) demonstrated that the generation of NKT1 cells was impaired by ectopic STAT5 activation (<xref ref-type="fig" rid="f6">
<bold>Figure 6F</bold>
</xref>). T cell development in general, however, was not negatively affected by the constitutive activation of STAT5 (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 8B</bold>
</xref>). As such, the cell numbers of preselection DP thymocytes remained unaffected (<xref ref-type="fig" rid="f6">
<bold>Figure 6F</bold>
</xref>), and the generation of memory-phenotype CD8 T cells was rather increased in CA-STAT5<sup>Tg</sup> thymocytes (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 8C</bold>
</xref>). Thus, the detrimental effect of STAT5 activation was limited to the generation of <italic>i</italic>NKT cells. Collectively, these results identify and demonstrate STAT5 as a major player acting downstream of IL-2R&#x3b2; to control the development of thymic <italic>i</italic>NKT cells.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>
<italic>i</italic>NKT cells comprise three major subsets that are characterized by distinct transcription factor and cytokine expression. Although TCR signaling is considered to play a decisive role in the generation and subset differentiation of <italic>i</italic>NKT cells (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B43">43</xref>), intrathymic cytokines also play important roles in these processes (<xref ref-type="bibr" rid="B44">44</xref>). As such, the &#x3b3;c family cytokine IL-15 is a critical factor in thymic <italic>i</italic>NKT cell generation that also contributes to the subset specification of <italic>i</italic>NKT cells (<xref ref-type="bibr" rid="B11">11</xref>). Consistent with an IL-15 requirement for NKT1 cell differentiation, the signaling-competent IL-15 receptor heterodimer&#x2014;<italic>i.e.</italic>, IL-2R&#x3b2;/&#x3b3;c&#x2014;is mostly expressed on NKT1 cells, but not on NKT2 and NKT17 cells (<xref ref-type="bibr" rid="B10">10</xref>). This raises the question whether IL-2R&#x3b2; expression is specifically induced on NKT1 cells or whether IL-2R&#x3b2; could be induced on all <italic>i</italic>NKT cells but is then terminated upon differentiation into NKT2 and NKT17 cells. Furthermore, it was unclear whether IL-2R&#x3b2; expression would be sufficient to impose NKT1 subset fate so that forced expression of IL-2R&#x3b2; would direct <italic>i</italic>NKT cells into NKT1 cells. Here, we addressed these questions using a series of genetically engineered mouse models, and we identified IL-2R&#x3b2; as a critical regulator of thymic <italic>i</italic>NKT cell generation whose abundance and timing of expression dramatically affected the generation of <italic>i</italic>NKT cells. These findings reveal previously unappreciated aspects of cytokine receptor expression in controlling the development of <italic>i</italic>NKT cells, and they propose a model of <italic>i</italic>NKT differentiation that is regulated by the timing and abundance of cytokine receptor expression.</p>
<p>The generation of thymic <italic>i</italic>NKT cells is currently explained by two competing but not mutually exclusive models of differentiation (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B45">45</xref>). In the conventional or &#x201c;linear maturation&#x201d; model, preselection thymocytes that have recombined a functional V&#x3b1;14-J&#x3b1;18 TCR&#x3b1; chain are positively selected to become immature ST0 <italic>i</italic>NKT cells. ST0 <italic>i</italic>NKT cells then mature along a developmental pathway defined by CD44 and NK1.1 expression, culminating in end differentiated CD44<sup>+</sup>NK1.1<sup>+</sup> ST3 <italic>i</italic>NKT effector cells. Under this scenario, CD44<sup>+</sup>NK1.1<sup>&#x2013;</sup> ST2 <italic>i</italic>NKT cells, which are IL-2R&#x3b2;-negative, would give rise to ST3 <italic>i</italic>NKT cells that are IL-2R&#x3b2;-positive. However, the cellular signals that would induce the initial upregulation of IL-2R&#x3b2; remain unknown. Notably, such a requirement for IL-2R&#x3b2; expression that precedes the IL-15-mediated generation of NKT1 cells is also found in the alternative &#x201c;lineage differentiation&#x201d; model (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B45">45</xref>). While NKT1 cell differentiation depends on IL-15, the IL-2R&#x3b2;, which is necessary for IL-15 signaling, is not expressed on immature <italic>i</italic>NKT cells. Thus, IL-2R&#x3b2; expression is carefully timed so that preselection thymocytes lack IL-2R&#x3b2; but is then specifically induced on NKT1-committed postselection immature <italic>i</italic>NKT cells to drive their maturation into NKT1 subset <italic>i</italic>NKT cells.</p>
<p>The molecular pathway that upregulates IL-2R&#x3b2; and drives NKT1 cell fate is not fully understood. However, it likely involves molecules downstream of TCR signaling because differences in TCR signaling strength are acknowledged to drive <italic>i</italic>NKT subset fate decisions (<xref ref-type="bibr" rid="B42">42</xref>). In this regard, the transcription factor Egr2 is of particular interest (<xref ref-type="bibr" rid="B46">46</xref>), because its relative abundance is associated with <italic>i</italic>NKT subset differentiation (<xref ref-type="bibr" rid="B42">42</xref>). Egr2 expression is upregulated by TCR-induced calcium signaling and correlates with the strength of TCR signaling (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B47">47</xref>). Notably, NKT2 cell generation is thought to be driven by strong TCR signaling whereas NKT1 cell differentiation is proposed to be mediated by weak TCR signaling (<xref ref-type="bibr" rid="B42">42</xref>). Incidentally, NKT2 cells contain large amounts of Egr2 whereas NKT1 cells express small amounts of Egr2. Such distinct amounts of Egr2 expression presumably results in the graded expression of PLZF whose abundance correlates with <italic>i</italic>NKT subset specification (<xref ref-type="bibr" rid="B48">48</xref>). Thus, the TCR-centric view proposes that distinct amounts of Egr2 would induce different levels of PLZF, which would then determine <italic>i</italic>NKT subset identity. Interestingly, however, Egr2 was also found to bind the IL-2R&#x3b2; promoter and thus to induce IL-2R&#x3b2; expression (<xref ref-type="bibr" rid="B47">47</xref>). Consequently, we hypothesized that Egr2 could induce the expression of IL-2R&#x3b2; in immature <italic>i</italic>NKT cells to permit their differentiation into NKT1 cells. According to this scenario, TCR signaling would be required to specify NKT1 fate by upregulating IL-2R&#x3b2; expression, and cytokine receptor signaling would be then required to drive NKT1 subset differentiation by IL-15 signaling. Altogether, such model reconciles the two concurrent perspectives of <italic>i</italic>NKT cell development so that TCR and cytokine signals play distinct but nonredundant roles in the subset differentiation of <italic>i</italic>NKT cells.</p>
<p>Because IL-2R&#x3b2; plays such a critical role in NKT1 subset commitment, we were surprised to find that the increased abundance of IL-2R&#x3b2; in IL-2R&#x3b2;<sup>Tg</sup> mice did not promote but rather suppressed the generation of thymic <italic>i</italic>NKT cells, specifically of the NKT1 subset. A detrimental effect of forced IL-2R&#x3b2; expression had been previously reported for NK cells where a hematopoietic lineage-specific IL-2R&#x3b2; transgene was found to suppress the generation of NK1.1<sup>+</sup> cells (<xref ref-type="bibr" rid="B49">49</xref>). Whether this NK1.1<sup>+</sup> population also comprise <italic>i</italic>NKT cells, including stage 3 NKT1 cells, is unclear from that study. If such would be the case, however, these results would further bolster a detrimental effect of IL-2R&#x3b2; on <italic>i</italic>NKT cell generation whose molecular basis remains currently unclear to us.</p>
<p>Nonetheless, we considered two important findings regarding the generation of <italic>i</italic>NKT cells in IL-2R&#x3b2;<sup>Tg</sup> mice. First, unlike NKT1 cells, NKT2 and NKT17 cells in WT mice do not express IL-2R&#x3b2; (<xref ref-type="bibr" rid="B10">10</xref>) Surprisingly, we found that the few NKT2 and NKT17 cells that arise in IL-2R&#x3b2;<sup>Tg</sup> mice also did not express IL-2R&#x3b2; proteins. Therefore, the NKT2 and NKT17 cells in IL-2R&#x3b2;<sup>Tg</sup> mice could be either transgene escapees or they could have downregulated the expression of transgenic IL-2R&#x3b2;. We favor the latter case because the IL-2R&#x3b2;<sup>Tg</sup> is driven by the human <italic>CD2</italic> mini-cassette, whose activity is downregulated upon positive selection, so that transgene expression substantially diminishes in postselection thymocytes (<xref ref-type="bibr" rid="B50">50</xref>). Regardless, we consider the IL-2R&#x3b2;<sup>Tg</sup> model not adequate to assess the effect of forced IL-2R&#x3b2; expression on NKT2 and NKT17 cells, simply because the IL-2R&#x3b2;<sup>Tg</sup> fails to be expressed in these <italic>i</italic>NKT subsets. Second, we wish to underscore that the IL-2R&#x3b2;<sup>Tg</sup> is prematurely expressed on immature thymocytes, including the immature ST0 <italic>i</italic>NKT cells. IL-2R&#x3b2; is normally absent in the ST0 <italic>i</italic>NKT precursors of WT mice, an observation contrasting the IL-2R&#x3b2; expression in IL-2R&#x3b2;<sup>Tg</sup> ST0 <italic>i</italic>NKT cells which are highly abundant in IL-2R&#x3b2;. Consequently, ST0 <italic>i</italic>NKT cells in IL-2R&#x3b2;<sup>Tg</sup> mice can be signaled by intrathymic IL-15 whereas WT ST0 <italic>i</italic>NKT cells cannot respond to IL-15. Based on these results, we hypothesize that premature and possibly sustained IL-15 signaling in immature ST0 <italic>i</italic>NKT cells would be detrimental for NKT1 cell generation.</p>
<p>Additionally, we appreciate the need to determine why premature IL-15 signaling in ST0 <italic>i</italic>NKT cells would negatively affect thymic <italic>i</italic>NKT cell generation. IL-15-induced STAT5 phosphorylation is usually considered beneficial for T cells because it induces the expression of anti-apoptotic Bcl-2 and upregulates metabolic activities. Thus, IL-15 signaling should promote and not inhibit <italic>i</italic>NKT cell generation. However, STAT5 activation also suppresses the induction of Bcl6, which is a critical transcription factor for <italic>i</italic>NKT cell generation (<xref ref-type="bibr" rid="B51">51</xref>). Bcl-6 is selectively and highly expressed on ST0 <italic>i</italic>NKT cells before they proliferate and differentiate into mature <italic>i</italic>NKT cells. Bcl-6 is also developmentally necessary because Bcl-6-deficiency is associated with impaired thymic <italic>i</italic>NKT cell generation (<xref ref-type="bibr" rid="B51">51</xref>). Importantly, IL-2 receptor-induced pSTAT5 potently suppresses Bcl-6 expression (<xref ref-type="bibr" rid="B52">52</xref>&#x2013;<xref ref-type="bibr" rid="B54">54</xref>). Therefore, STAT5 activation in ST0 <italic>i</italic>NKT cells could suppress the expression of Bcl-6, which, in turn, could impair the generation of thymic <italic>i</italic>NKT cells. These results lead to a model of <italic>i</italic>NKT cell development where IL-2R&#x3b2; expression must be precisely timed so that ST0 <italic>i</italic>NKT cells suppress IL-2R&#x3b2; expression to prevent premature IL-15 signaling, but then a subset of post-ST0 <italic>i</italic>NKT cells would rapidly induce IL-2R&#x3b2; to initiate IL-15-induced NKT1 lineage differentiation.</p>
<p>Lastly, we wish to point out that the T-bet-ZsGreen reporter mouse revealed a new developmentally intermediate stage in NKT1 cell development that can be identified by intermediate level of T-bet protein expression and T-bet mRNA transcription (as demonstrated by T-bet-ZsGreen reporter expression). Such ZsGreen<sup>int</sup>T-bet<sup>int</sup> <italic>i</italic>NKT cells were NKT1 lineage committed but not fully differentiated NKT1 cells, as they lacked ROR&#x3b3;t expression but had not fully upregulated T-bet protein expression. The ZsGreen<sup>int</sup>T-bet<sup>int</sup> <italic>i</italic>NKT cells were further marked by their intermediate level of PLZF protein expression which was not downregulated to the amounts found in mature NKT1 cells (<xref ref-type="bibr" rid="B48">48</xref>). Thus, ZsGreen<sup>int</sup>T-bet<sup>int</sup> <italic>i</italic>NKT cells are NKT1 lineage committed but not fully mature NKT1 cells. Because ZsGreen<sup>int</sup>T-bet<sup>int</sup> <italic>i</italic>NKT cells were present in both WT and IL-2R&#x3b2;<sup>Tg</sup> mice, these data indicate that the forced IL-2R&#x3b2; expression did not interfere with NKT1 lineage commitment but rather with the maturation of NKT1 cells.</p>
<p>Collectively, here, we demonstrated the importance of cytokine signaling in NKT1 lineage differentiation by altering the timing and abundance of IL-2R&#x3b2; expression, independently of TCR expression or signaling. These results document the significance of cytokines and their receptor expression in determining <italic>i</italic>NKT lineage fate, and further suggest a role for cytokines in parallel or in association with TCR signaling to shape the effector function of T cells.</p>
</sec>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by National Cancer Institute Animal Care and Use Committee.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>HW designed and performed the experiments, analyzed the data, and contributed to the writing of the manuscript. HK, AC, PA, and RG provided expertise, analyzed the data, and commented on the manuscript. J-HP conceived the project, analyzed the data, and wrote the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank Drs. Joo-Young Park (Seoul National University) and Damian Kovalovsky (National Cancer Institute, NIH) for critical review and discussion of this manuscript. This study has been supported by the Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research.</p>
</ack>
<sec id="s9" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2021.642856/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2021.642856/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="DataSheet_1.pdf" id="SM1" mimetype="application/pdf"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Etzensperger</surname> <given-names>R</given-names>
</name>
<name>
<surname>Kadakia</surname> <given-names>T</given-names>
</name>
<name>
<surname>Tai</surname> <given-names>X</given-names>
</name>
<name>
<surname>Alag</surname> <given-names>A</given-names>
</name>
<name>
<surname>Guinter</surname> <given-names>TI</given-names>
</name>
<name>
<surname>Egawa</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Identification of Lineage-Specifying Cytokines That Signal All CD8(+)-Cytotoxic-Lineage-Fate &#x2018;Decisions&#x2019; in the Thymus</article-title>. <source>Nat Immunol</source> (<year>2017</year>) <volume>18</volume>:<page-range>1218&#x2013;27</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.3847</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Adoro</surname> <given-names>S</given-names>
</name>
<name>
<surname>Guinter</surname> <given-names>T</given-names>
</name>
<name>
<surname>Erman</surname> <given-names>B</given-names>
</name>
<name>
<surname>Alag</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Catalfamo</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Signaling by Intrathymic Cytokines, Not T Cell Antigen Receptors, Specifies CD8 Lineage Choice and Promotes the Differentiation of Cytotoxic-Lineage T Cells</article-title>. <source>Nat Immunol</source> (<year>2010</year>) <volume>11</volume>:<page-range>257&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.1840</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>JX</given-names>
</name>
<name>
<surname>Leonard</surname> <given-names>WJ</given-names>
</name>
</person-group>. <article-title>The Common Cytokine Receptor Gamma Chain Family of Cytokines</article-title>. <source>Cold Spring Harb Perspect Biol</source> (<year>2018</year>) <volume>10</volume>:<fpage>a028449</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/cshperspect.a028449</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname> <given-names>C</given-names>
</name>
<name>
<surname>Luckey</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Park</surname> <given-names>JH</given-names>
</name>
</person-group>. <article-title>Intrathymic IL-7: The Where, When, and Why of IL-7 Signaling During T Cell Development</article-title>. <source>Semin Immunol</source> (<year>2012</year>) <volume>24</volume>:<page-range>151&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.smim.2012.02.002</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weinreich</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Odumade</surname> <given-names>OA</given-names>
</name>
<name>
<surname>Jameson</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Hogquist</surname> <given-names>KA</given-names>
</name>
</person-group>. <article-title>T Cells Expressing the Transcription Factor PLZF Regulate the Development of Memory-Like CD8+ T Cells</article-title>. <source>Nat Immunol</source> (<year>2010</year>) <volume>11</volume>:<page-range>709&#x2013;16</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.1898</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hemmers</surname> <given-names>S</given-names>
</name>
<name>
<surname>Schizas</surname> <given-names>M</given-names>
</name>
<name>
<surname>Azizi</surname> <given-names>E</given-names>
</name>
<name>
<surname>Dikiy</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-2 Production by Self-Reactive CD4 Thymocytes Scales Regulatory T Cell Generation in the Thymus</article-title>. <source>J Exp Med</source> (<year>2019</year>) <volume>216</volume>:<page-range>2466&#x2013;78</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20190993</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hogquist</surname> <given-names>K</given-names>
</name>
<name>
<surname>Georgiev</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Recent Advances in iNKT Cell Development</article-title>. <source>F1000Res</source> (<year>2020</year>) <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.12688/f1000research.21378.1</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gapin</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Development of Invariant Natural Killer T Cells</article-title>. <source>Curr Opin Immunol</source> (<year>2016</year>) <volume>39</volume>:<fpage>68</fpage>&#x2013;<lpage>74</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.coi.2016.01.001</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krovi</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Gapin</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Invariant Natural Killer T Cell Subsets-More Than Just Developmental Intermediates</article-title>. <source>Front Immunol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>1393</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.01393</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>YJ</given-names>
</name>
<name>
<surname>Holzapfel</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jameson</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Hogquist</surname> <given-names>KA</given-names>
</name>
</person-group>. <article-title>Steady-State Production of IL-4 Modulates Immunity in Mouse Strains and is Determined by Lineage Diversity of Inkt Cells</article-title>. <source>Nat Immunol</source> (<year>2013</year>) <volume>14</volume>:<page-range>1146&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.2731</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gordy</surname> <given-names>LE</given-names>
</name>
<name>
<surname>Bezbradica</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Flyak</surname> <given-names>AI</given-names>
</name>
<name>
<surname>Spencer</surname> <given-names>CT</given-names>
</name>
<name>
<surname>Dunkle</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-15 Regulates Homeostasis and Terminal Maturation of NKT Cells</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>187</volume>:<page-range>6335&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1003965</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monteiro</surname> <given-names>M</given-names>
</name>
<name>
<surname>Almeida</surname> <given-names>CF</given-names>
</name>
<name>
<surname>Agua-Doce</surname> <given-names>A</given-names>
</name>
<name>
<surname>Graca</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Induced IL-17-Producing Invariant NKT Cells Require Activation in Presence of TGF-Beta and IL-1beta</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>190</volume>:<page-range>805&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1201010</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lucas</surname> <given-names>B</given-names>
</name>
<name>
<surname>White</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Cosway</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>Parnell</surname> <given-names>SM</given-names>
</name>
<name>
<surname>James</surname> <given-names>KD</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>ND</given-names>
</name>
<etal/>
</person-group>. <article-title>Diversity in Medullary Thymic Epithelial Cells Controls the Activity and Availability of iNKT Cells</article-title>. <source>Nat Commun</source> (<year>2020</year>) <volume>11</volume>:<fpage>2198</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-020-16041-x</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Catlett</surname> <given-names>IM</given-names>
</name>
<name>
<surname>Hedrick</surname> <given-names>SM</given-names>
</name>
</person-group>. <article-title>Suppressor of Cytokine Signaling 1 is Required for the Differentiation of CD4+ T Cells</article-title>. <source>Nat Immunol</source> (<year>2005</year>) <volume>6</volume>:<page-range>715&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni1211</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vidalain</surname> <given-names>PO</given-names>
</name>
<name>
<surname>Laine</surname> <given-names>D</given-names>
</name>
<name>
<surname>Zaffran</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Azocar</surname> <given-names>O</given-names>
</name>
<name>
<surname>Servet-Delprat</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wild</surname> <given-names>TF</given-names>
</name>
<etal/>
</person-group>. <article-title>Interferons Mediate Terminal Differentiation of Human Cortical Thymic Epithelial Cells</article-title>. <source>J Virol</source> (<year>2002</year>) <volume>76</volume>:<page-range>6415&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/jvi.76.13.6415-6424.2002</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Ligons</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Park</surname> <given-names>JH</given-names>
</name>
</person-group>. <article-title>Out-Sourcing for Trans-Presentation: Assessing T Cell Intrinsic and Extrinsic IL-15 Expression With Il15 Gene Reporter Mice</article-title>. <source>Immune Netw</source> (<year>2018</year>) <volume>18</volume>:<elocation-id>e13</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.4110/in.2018.18.e13</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>White</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Jenkinson</surname> <given-names>WE</given-names>
</name>
<name>
<surname>Cowan</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Parnell</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Bacon</surname> <given-names>A</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>ND</given-names>
</name>
<etal/>
</person-group>. <article-title>An Essential Role for Medullary Thymic Epithelial Cells During the Intrathymic Development of Invariant NKT Cells</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>192</volume>:<page-range>2659&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1303057</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohteki</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ho</surname> <given-names>S</given-names>
</name>
<name>
<surname>Suzuki</surname> <given-names>H</given-names>
</name>
<name>
<surname>Mak</surname> <given-names>TW</given-names>
</name>
<name>
<surname>Ohashi</surname> <given-names>PS</given-names>
</name>
</person-group>. <article-title>Role for IL-15/IL-15 Receptor Beta-Chain in Natural Killer 1.1+ T Cell Receptor-Alpha Beta+ Cell Development</article-title>. <source>J Immunol</source> (<year>1997</year>) <volume>159</volume>:<page-range>5931&#x2013;5</page-range>.</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Minagawa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Watanabe</surname> <given-names>H</given-names>
</name>
<name>
<surname>Miyaji</surname> <given-names>C</given-names>
</name>
<name>
<surname>Tomiyama</surname> <given-names>K</given-names>
</name>
<name>
<surname>Shimura</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ito</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Enforced Expression of Bcl-2 Restores the Number of NK Cells, But Does Not Rescue the Impaired Development of NKT Cells or Intraepithelial Lymphocytes, in IL-2/IL-15 Receptor Beta-Chain-Deficient Mice</article-title>. <source>J Immunol</source> (<year>2002</year>) <volume>169</volume>:<page-range>4153&#x2013;60</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.169.8.4153</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waickman</surname> <given-names>AT</given-names>
</name>
<name>
<surname>Ligons</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Hwang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Park</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Lazarevic</surname> <given-names>V</given-names>
</name>
<name>
<surname>Sato</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>CD4 Effector T Cell Differentiation is Controlled by IL-15 That is Expressed and Presented in Trans</article-title>. <source>Cytokine</source> (<year>2017</year>) <volume>99</volume>:<page-range>266&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cyto.2017.08.004</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chinen</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kannan</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Levine</surname> <given-names>AG</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>X</given-names>
</name>
<name>
<surname>Klein</surname> <given-names>U</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>An Essential Role for the IL-2 Receptor in Treg Cell Function</article-title>. <source>Nat Immunol</source> (<year>2016</year>) <volume>17</volume>:<page-range>1322&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.3540</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kundig</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Furlonger</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wakeham</surname> <given-names>A</given-names>
</name>
<name>
<surname>Timms</surname> <given-names>E</given-names>
</name>
<name>
<surname>Matsuyama</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Deregulated T Cell Activation and Autoimmunity in Mice Lacking Interleukin-2 Receptor Beta</article-title>. <source>Science</source> (<year>1995</year>) <volume>268</volume>:<page-range>1472&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.7770771</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Laouar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Denzin</surname> <given-names>LK</given-names>
</name>
<name>
<surname>Sant&#x2019;Angelo</surname> <given-names>DB</given-names>
</name>
</person-group>. <article-title>Zbtb16 (PLZF) is Stably Suppressed and Not Inducible in Non-Innate T Cells Via T Cell Receptor-Mediated Signaling</article-title>. <source>Sci Rep</source> (<year>2015</year>) <volume>5</volume>:<elocation-id>12113</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/srep12113</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burchill</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Goetz</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Prlic</surname> <given-names>M</given-names>
</name>
<name>
<surname>O&#x2019;Neil</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Harmon</surname> <given-names>IR</given-names>
</name>
<name>
<surname>Bensinger</surname> <given-names>SJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Distinct Effects of STAT5 Activation on CD4+ and CD8+ T Cell Homeostasis: Development of CD4+CD25+ Regulatory T Cells Versus CD8+ Memory T Cells</article-title>. <source>J Immunol</source> (<year>2003</year>) <volume>171</volume>:<page-range>5853&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.171.11.5853</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jankovic</surname> <given-names>D</given-names>
</name>
<name>
<surname>Oler</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>G</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>The Transcription Factor T-Bet is Induced by Multiple Pathways and Prevents an Endogenous Th2 Cell Program During Th1 Cell Responses</article-title>. <source>Immunity</source> (<year>2012</year>) <volume>37</volume>:<page-range>660&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2012.09.007</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Kwon</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>EY</given-names>
</name>
<name>
<surname>Fink</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>HK</given-names>
</name>
<name>
<surname>Park</surname> <given-names>JH</given-names>
</name>
</person-group>. <article-title>CD24(+) Cell Depletion Permits Effective Enrichment of Thymic iNKT Cells While Preserving Their Subset Composition</article-title>. <source>Immune Netw</source> (<year>2019</year>) <volume>19</volume>:<elocation-id>e14</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.4110/in.2019.19.e14</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kadakia</surname> <given-names>T</given-names>
</name>
<name>
<surname>Tai</surname> <given-names>X</given-names>
</name>
<name>
<surname>Kruhlak</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wisniewski</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hwang</surname> <given-names>IY</given-names>
</name>
<name>
<surname>Roy</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>E-Protein-Regulated Expression of CXCR4 Adheres Preselection Thymocytes to the Thymic Cortex</article-title>. <source>J Exp Med</source> (<year>2019</year>) <volume>216</volume>:<page-range>1749&#x2013;61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20182285</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benlagha</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kyin</surname> <given-names>T</given-names>
</name>
<name>
<surname>Beavis</surname> <given-names>A</given-names>
</name>
<name>
<surname>Teyton</surname> <given-names>L</given-names>
</name>
<name>
<surname>Bendelac</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>A Thymic Precursor to the NK T Cell Lineage</article-title>. <source>Science</source> (<year>2002</year>) <volume>296</volume>:<page-range>553&#x2013;5</page-range>. doi: <pub-id pub-id-type="doi">10.1126/science.1069017</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raberger</surname> <given-names>J</given-names>
</name>
<name>
<surname>Schebesta</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sakaguchi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Boucheron</surname> <given-names>N</given-names>
</name>
<name>
<surname>Blomberg</surname> <given-names>KE</given-names>
</name>
<name>
<surname>Berglof</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>The Transcriptional Regulator PLZF Induces the Development of CD44 High Memory Phenotype T Cells</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2008</year>) <volume>105</volume>:<page-range>17919&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0805733105</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kovalovsky</surname> <given-names>D</given-names>
</name>
<name>
<surname>Alonzo</surname> <given-names>ES</given-names>
</name>
<name>
<surname>Uche</surname> <given-names>OU</given-names>
</name>
<name>
<surname>Eidson</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nichols</surname> <given-names>KE</given-names>
</name>
<name>
<surname>Sant&#x2019;Angelo</surname> <given-names>DB</given-names>
</name>
</person-group>. <article-title>PLZF Induces the Spontaneous Acquisition of Memory/Effector Functions in T Cells Independently of NKT Cell-Related Signals</article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>184</volume>:<page-range>6746&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1000776</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lord</surname> <given-names>JD</given-names>
</name>
<name>
<surname>McIntosh</surname> <given-names>BC</given-names>
</name>
<name>
<surname>Greenberg</surname> <given-names>PD</given-names>
</name>
<name>
<surname>Nelson</surname> <given-names>BH</given-names>
</name>
</person-group>. <article-title>The IL-2 Receptor Promotes Lymphocyte Proliferation and Induction of the C-Myc, Bcl-2, and Bcl-X Genes Through the Trans-Activation Domain of Stat5</article-title>. <source>J Immunol</source> (<year>2000</year>) <volume>164</volume>:<page-range>2533&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.164.5.2533</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname> <given-names>G</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>A</given-names>
</name>
<name>
<surname>Dee</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Malek</surname> <given-names>TR</given-names>
</name>
</person-group>. <article-title>IL-2R Signaling is Essential for Functional Maturation of Regulatory T Cells During Thymic Development</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>190</volume>:<page-range>1567&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1201218</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soper</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Kasprowicz</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Ziegler</surname> <given-names>SF</given-names>
</name>
</person-group>. <article-title>IL-2Rbeta Links IL-2R Signaling With Foxp3 Expression</article-title>. <source>Eur J Immunol</source> (<year>2007</year>) <volume>37</volume>:<page-range>1817&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.200737101</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keller</surname> <given-names>HR</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>HK</given-names>
</name>
<name>
<surname>Jo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gress</surname> <given-names>RE</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>C</given-names>
</name>
<name>
<surname>Park</surname> <given-names>JH</given-names>
</name>
</person-group>. <article-title>The Abundance and Availability of Cytokine Receptor IL-2Rbeta (CD122) Constrain the Lymphopenia-Induced Homeostatic Proliferation of Naive CD4 T Cells</article-title>. <source>J Immunol</source> (<year>2020</year>) <volume>204</volume>:<page-range>3227&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1901276</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dickgreber</surname> <given-names>N</given-names>
</name>
<name>
<surname>Farrand</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>van Panhuys</surname> <given-names>N</given-names>
</name>
<name>
<surname>Knight</surname> <given-names>DA</given-names>
</name>
<name>
<surname>McKee</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Chong</surname> <given-names>ML</given-names>
</name>
<etal/>
</person-group>. <article-title>Immature Murine NKT Cells Pass Through a Stage of Developmentally Programmed Innate IL-4 Secretion</article-title>. <source>J Leukoc Biol</source> (<year>2012</year>) <volume>92</volume>:<fpage>999</fpage>&#x2013;<lpage>1009</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1189/jlb.0512242</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Jo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ko</surname> <given-names>E</given-names>
</name>
<name>
<surname>Luckey</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Park</surname> <given-names>YK</given-names>
</name>
<name>
<surname>Park</surname> <given-names>SH</given-names>
</name>
<etal/>
</person-group>. <article-title>Soluble Gamma c Cytokine Receptor Suppresses IL-15 Signaling and Impairs iNKT Cell Development in the Thymus</article-title>. <source>Sci Rep</source> (<year>2016</year>) <volume>6</volume>:<elocation-id>36962</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/srep36962</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kennedy</surname> <given-names>MK</given-names>
</name>
<name>
<surname>Glaccum</surname> <given-names>M</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>SN</given-names>
</name>
<name>
<surname>Butz</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Viney</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Embers</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Reversible Defects in Natural Killer and Memory CD8 T Cell Lineages in Interleukin 15-Deficient Mice</article-title>. <source>J Exp Med</source> (<year>2000</year>) <volume>191</volume>:<page-range>771&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.191.5.771</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ranson</surname> <given-names>T</given-names>
</name>
<name>
<surname>Vosshenrich</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Corcuff</surname> <given-names>E</given-names>
</name>
<name>
<surname>Richard</surname> <given-names>O</given-names>
</name>
<name>
<surname>Muller</surname> <given-names>W</given-names>
</name>
<name>
<surname>Di Santo</surname> <given-names>JP</given-names>
</name>
</person-group>. <article-title>IL-15 is an Essential Mediator of Peripheral NK-Cell Homeostasis</article-title>. <source>Blood</source> (<year>2003</year>) <volume>101</volume>:<page-range>4887&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2002-11-3392</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fehniger</surname> <given-names>TA</given-names>
</name>
<name>
<surname>Suzuki</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ponnappan</surname> <given-names>A</given-names>
</name>
<name>
<surname>VanDeusen</surname> <given-names>JB</given-names>
</name>
<name>
<surname>Cooper</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Florea</surname> <given-names>SM</given-names>
</name>
<etal/>
</person-group>. <article-title>Fatal Leukemia in Interleukin 15 Transgenic Mice Follows Early Expansions in Natural Killer and Memory Phenotype CD8+ T Cells</article-title>. <source>J Exp Med</source> (<year>2001</year>) <volume>193</volume>:<page-range>219&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.193.2.219</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spolski</surname> <given-names>R</given-names>
</name>
<name>
<surname>Li</surname> <given-names>P</given-names>
</name>
<name>
<surname>Leonard</surname> <given-names>WJ</given-names>
</name>
</person-group>. <article-title>Biology and Regulation of IL-2: From Molecular Mechanisms to Human Therapy</article-title>. <source>Nat Rev Immunol</source> (<year>2018</year>) <volume>18</volume>:<page-range>648&#x2013;59</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41577-018-0046-y</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Watford</surname> <given-names>WT</given-names>
</name>
<name>
<surname>Bream</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Yamaoka</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hissong</surname> <given-names>BD</given-names>
</name>
<etal/>
</person-group>. <article-title>Stat5a/B are Essential for Normal Lymphoid Development and Differentiation</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2006</year>) <volume>103</volume>:<page-range>1000&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0507350103</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tuttle</surname> <given-names>KD</given-names>
</name>
<name>
<surname>Krovi</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bedel</surname> <given-names>R</given-names>
</name>
<name>
<surname>Harmacek</surname> <given-names>L</given-names>
</name>
<name>
<surname>Peterson</surname> <given-names>LK</given-names>
</name>
<etal/>
</person-group>. <article-title>TCR Signal Strength Controls Thymic Differentiation of iNKT Cell Subsets</article-title>. <source>Nat Commun</source> (<year>2018</year>) <volume>9</volume>:<fpage>2650</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-018-05026-6</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dashtsoodol</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bortoluzzi</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>and Schmidt-Supprian M. T Cell Receptor Expression Timing and Signal Strength in the Functional Differentiation of Invariant Natural Killer T Cells</article-title>. <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>841</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.00841</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Hogquist</surname> <given-names>KA</given-names>
</name>
</person-group>. <article-title>How Lipid-Specific T Cells Become Effectors: The Differentiation of iNKT Subsets</article-title>. <source>Front Immunol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>1450</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.01450</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwon</surname> <given-names>DI</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>YJ</given-names>
</name>
</person-group>. <article-title>Lineage Differentiation Program of Invariant Natural Killer T Cells</article-title>. <source>Immune Netw</source> (<year>2017</year>) <volume>17</volume>:<page-range>365&#x2013;77</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4110/in.2017.17.6.365</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lazarevic</surname> <given-names>V</given-names>
</name>
<name>
<surname>Zullo</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Schweitzer</surname> <given-names>MN</given-names>
</name>
<name>
<surname>Staton</surname> <given-names>TL</given-names>
</name>
<name>
<surname>Gallo</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Crabtree</surname> <given-names>GR</given-names>
</name>
<etal/>
</person-group>. <article-title>The Gene Encoding Early Growth Response 2, a Target of the Transcription Factor NFAT, is Required for the Development and Maturation of Natural Killer T Cells</article-title>. <source>Nat Immunol</source> (<year>2009</year>) <volume>10</volume>:<page-range>306&#x2013;13</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.1696</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seiler</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Mathew</surname> <given-names>R</given-names>
</name>
<name>
<surname>Liszewski</surname> <given-names>MK</given-names>
</name>
<name>
<surname>Spooner</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Barr</surname> <given-names>K</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Elevated and Sustained Expression of the Transcription Factors Egr1 and Egr2 Controls NKT Lineage Differentiation in Response to TCR Signaling</article-title>. <source>Nat Immunol</source> (<year>2012</year>) <volume>13</volume>:<page-range>264&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.2230</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>JY</given-names>
</name>
<name>
<surname>DiPalma</surname> <given-names>DT</given-names>
</name>
<name>
<surname>Kwon</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fink</surname> <given-names>J</given-names>
</name>
<name>
<surname>Park</surname> <given-names>JH</given-names>
</name>
</person-group>. <article-title>Quantitative Difference in PLZF Protein Expression Determines iNKT Lineage Fate and Controls Innate CD8 T Cell Generation</article-title>. <source>Cell Rep</source> (<year>2019</year>) <volume>27</volume>:<fpage>2548</fpage>&#x2013;<lpage>57.e4</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.celrep.2019.05.012</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suwa</surname> <given-names>H</given-names>
</name>
<name>
<surname>Tanaka</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kitamura</surname> <given-names>F</given-names>
</name>
<name>
<surname>Shiohara</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kuida</surname> <given-names>K</given-names>
</name>
<name>
<surname>Miyasaka</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Dysregulated Expression of the IL-2 Receptor Beta-Chain Abrogates Development of NK Cells and Thy-1+ Dendritic Epidermal Cells in Transgenic Mice</article-title>. <source>Int Immunol</source> (<year>1995</year>) <volume>7</volume>:<page-range>1441&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/intimm/7.9.1441</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarafova</surname> <given-names>SD</given-names>
</name>
<name>
<surname>Van Laethem</surname> <given-names>F</given-names>
</name>
<name>
<surname>Adoro</surname> <given-names>S</given-names>
</name>
<name>
<surname>Guinter</surname> <given-names>T</given-names>
</name>
<name>
<surname>Sharrow</surname> <given-names>SO</given-names>
</name>
<name>
<surname>Feigenbaum</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Upregulation of CD4 Expression During MHC Class II-Specific Positive Selection is Essential for Error-Free Lineage Choice</article-title>. <source>Immunity</source> (<year>2009</year>) <volume>31</volume>:<page-range>480&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2009.07.006</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gioulbasani</surname> <given-names>M</given-names>
</name>
<name>
<surname>Galaras</surname> <given-names>A</given-names>
</name>
<name>
<surname>Grammenoudi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Moulos</surname> <given-names>P</given-names>
</name>
<name>
<surname>Dent</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Sigvardsson</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>The Transcription Factor BCL-6 Controls Early Development of Innate-Like T Cells</article-title>. <source>Nat Immunol</source> (<year>2020</year>) <volume>21</volume>:<page-range>1058&#x2013;69</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41590-020-0737-y</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walker</surname> <given-names>SR</given-names>
</name>
<name>
<surname>Nelson</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Frank</surname> <given-names>DA</given-names>
</name>
</person-group>. <article-title>STAT5 Represses BCL6 Expression by Binding to a Regulatory Region Frequently Mutated in Lymphomas</article-title>. <source>Oncogene</source> (<year>2007</year>) <volume>26</volume>:<page-range>224&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/sj.onc.1209775</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnston</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>YS</given-names>
</name>
<name>
<surname>Diamond</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Crotty</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>STAT5 is a Potent Negative Regulator of TFH Cell Differentiation</article-title>. <source>J Exp Med</source> (<year>2012</year>) <volume>209</volume>:<page-range>243&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20111174</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nurieva</surname> <given-names>RI</given-names>
</name>
<name>
<surname>Podd</surname> <given-names>A</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Alekseev</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Qi</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>STAT5 Protein Negatively Regulates T Follicular Helper (Tfh) Cell Generation and Function</article-title>. <source>J Biol Chem</source> (<year>2012</year>) <volume>287</volume>:<page-range>11234&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M111.324046</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>